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Resident macrophages are essential for the maintenance of tissue homeostasis as they 
participate in clearance of apoptotic cells and tissue remodelling and repair. In recent 
years, there has been an increased interest in the study of adipose tissue macrophages 
(ATMs). In lean individuals, ATMs are important for the control of insulin sensitivity, 
thermogenesis, angiogenesis and adipose tissue development. In obesity, the number 
and phenotype of ATMs is altered, and is associated with chronic low grade systemic 
and local inflammation. These “pro-inflammatory” changes are postulated to 
contribute to the manifestation of metabolic syndrome. These findings have suggested 
that the pool of ATMs is heterogeneous and may change, especially during obesity. 
To date, the characterisation of ATMs has been limited largely to the F4/80/CD11b 
markers, however the hypothesis of this thesis is that ATMs have distinct phenotype 
and function that could influence, in different ways, tissue homeostasis. This thesis 
aims to characterise and phenotype ATM subsets in order to better understand their 
potential specific role in the tissue. During the course of this research, a novel 
population of Tim4+ resident ATMs were identified. An additional aim of this thesis 
was to elucidate their role in adipose tissue homeostasis. 
Partial bone marrow chimeras were used to identify macrophage origin. The main AT 
depots were shielded from irradiation and a donor BM was injected intravenously. 
After 8 weeks, the origin of macrophages was analysed using flow cytometry. Tim4, 
a phosphatidylserine receptor mediating phagocytosis of apoptotic cells and a marker 
found on resident macrophages in other tissues, was used for the first time in adipose 
tissue. Four subsets of ATMs were identified: F4/80highCD11c-Tim4+, F4/80highCD11c-
Tim4-; F4/80lowCD11c+Tim4-; F4/80lowCD11c-Tim4-. Interestingly, this newly 
described F4/80highTim4+ ATM subset showed the lowest non-host chimerism 
compared to the other ATMs, suggesting this is a main self-replenishing resident ATM 
population.  
To study the impact of obesity on ATM turnover, partial chimeric mice were fed HFD 
for 8 weeks. This increased the number of macrophages in AT. However, the different 
subsets of ATMs were differentially affected by the diet. Indeed, only a small 
proportion of Tim4+ ATMs derived from the bone marrow. In contrast, replenishment 
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of the 3 other subsets was almost fully dependent on the arrival of monocyte-derived 
cells from the bone marrow.  
TIMD4, the gene encoding for Tim4, has been highlighted in genetic studies as being 
linked with dyslipidaemia. This suggests that Tim4+ ATMs might play a role in lipid 
homeostasis. Further characterisation of Tim4 ATMs demonstrated that these Tim4+ 
ATMs are highly charged in neutral lipid, and also have an increased lysosomal 
activity (shown by lysotracker staining) compared to the other ATM subsets. Using 
blocking anti-Tim4 antibodies in vivo, I found that Tim4 contributed markedly to free 
fatty acid (FFA) release into the plasma after short-term and long term HFD feeding. 
In addition, in vitro and in vivo experiments demonstrated that Tim4 could be required 
for the uptake of neutral lipids and their integration into lysosomes for degradation, 
though this seems to be dependent on the nature of the lipid.   
Collectively, these results indicate that Tim4 plays a crucial role in the control of lipid 
trafficking under conditions when dietary lipid is in excess. Tim4 allows uptake of 
lipids by Tim4+ ATMs and subsequent release of FFA into the circulation. Finally, the 
presence of  Tim4+ lipid laden ATMs was demonstrated in the human omentum. This 
finding may lead to the discovery of new targets to improve metabolic health in obese 
patients.  
This work stresses the importance of resident ATM population in body lipid 
homeostasis as they could be involved in coping with lipid availability in the body and 




Obesity is a worldwide problem. It is associated with other diseases such as type 2 
diabetes, cardiovascular problems (atherosclerosis, heart attack) and cancer. During 
obesity, the dramatic expansion of fat tissue (which stores excess energy in a form of 
fat called triglyceride) is accompanied by an increase in white blood cells that move 
into the tissue from the blood in a process called inflammation. Inflammation usually 
occurs at sites of injury or infection and normally involves the recruitment white blood 
cells to the injured tissue so they kill the microbes or eliminate dead cells and help 
repair the tissue. In the context of obesity, the capacity of the fat cells to store excess 
energy (in the form of triglyceride, a lipid or fat) is exceeded and the fat cells become 
dysfunctional and die. Macrophages (derived from the Greek meaning big [macro] 
eater [phage]) are one of the main populations of white blood cells that are recruited 
to the tissue during inflammation, notably to clear and remove the dead cells. But in 
this process they also release signals that recruit more white blood cells and by doing 
so they participate in the inflammatory process. 
In order to understand how macrophages work during obesity and what they do in fat 
tissue, it is important to know what these cells are and if (under the umbrella 
description of macrophages as a key cell type), subtypes exist with different roles in 
the tissue. The aim of this thesis was to identify subtypes of macrophages within 
adipose tissue of mice, using specific cellular tags (markers), and to study the role of 
one particular macrophage subset that was identified, tagged with Tim4. Tim4 is a 
marker on the surface of macrophages that is usually involved in the recognition of 
dead cells. 
Normally during inflammation, the bone marrow produces fresh macrophages which 
travel via the blood to enter the inflamed tissue. Here, using mice as an experimental 
system, it was found that during the inflammation that is associated with obesity, not 
all macrophages found in adipose tissue come from the bone marrow. Indeed, 
macrophages identified by their Tim4 tag were able to multiply themselves in the 
adipose tissue of mice fed a HFD. Furthermore, these Tim4-tagged cells contained an 
expansion of structures within cells called lysosomes. Lysosomes are an acidic 
compartment of the cell which functions as a “recycling centre”, breaking down 
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protein and lipid molecules for re-use in other parts of the cell.  Moreover, these Tim4-
tagged macrophages were able to pick up (phagocytose, or “eat”) more lipids from the 
surrounding tissue than other macrophages were.  
In experiments in mice, blocking Tim4 activity led to a decrease in macrophage uptake 
of lipid molecules and the ability of the lysosomes in macrophages to act as recycling 
centres. The ingestion of a fat-rich meal normally increases lipid (in the form of free 
fatty acid) in the blood. However, blocking Tim4 activity prevented the normal 
increase in free fatty acids in the blood, indicating a role for Tim4 in the release of free 
fatty acids after fat feeding. These observations suggest that Tim4 tagged macrophages 
in adipose tissue, by virtue of their lysosomes, can break down large lipid molecules 
(such as triglycerides) into free fatty acids for release into the blood. In conclusion, 
this research has identified a new pathway controlling the levels of free fatty acid in 
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CHAPTER 1 INTRODUCTION 




The last decade brought to macrophage biology a revolution in terms of what 
researchers thought they knew about these innate immune cells. Historically, 
macrophages were believed to derive from bone marrow (BM) recruited monocytes 
differentiating in tissues (Davies et al. 2013). However, astonishingly, studies pointed 
out that macrophages can proliferate and be maintained independently from the BM, 
which gave rise to further questions about the initial origin of these resident cells 
(Davies et al. 2013). Adipose tissue macrophages (ATM) have been highlighted in 
studies about obesity, both in human and mice, as they represent the main subset of 
immune cells in the fat tissue and that their increase in number has been linked to the 
low grade inflammation associated with the metabolic complications of obesity 
(Weisberg et al. 2003; Carey N Lumeng, Bodzin, and Saltiel 2007 ). However, ATMs 
are still lacking from the most recent reviews about resident macrophages in tissues : 
it is not clear if all macrophages are recruited to the tissue (monocyte derived) or if a 
resident self-replenishing population exist. Moreover, ATMs fulfil different roles, and 
their heterogeneity of function in the tissue seem unappreciated(Thomas and Apovian 
2017). After defining what is adipose tissue and obesity, this introductory chapter will 
give an insight into what we know of the role of macrophage in adipose tissue but also 
what we can learn about macrophage biology, origin and metabolism in other tissues 
that can be transposed to AT. 
1.2 White adipose tissue, lipid homeostasis and 
obesity  
1.2.1 White adipose tissue: localisation and role  
White adipose tissue (WAT) is the principal site of energy storage in mammals. In 
healthy men and women, WAT represent 20 and 30%, respectively, of the body mass 
(Morigny et al. 2016). The energy is stored as fat in adipocytes, each one containing a 
unilocular lipid droplet made of triglycerides (TG) which are 3 fatty acids (FA) 
esterified on 1 glycerol. The rest of the tissue is composed of various other cell types 
such as preadipocytes, immune cells, endothelial cells, fibroblasts and nerves, 
collectively named stromal vascular fraction (SVF). WAT depots are found across the 
human and mouse body, the main depot being the visceral adipose tissue (VAT) and 
Chapter 1 Introduction 
 
 3 
the subcutaneous adipose tissue (SAT). In mouse, the VAT can be divided into gonadal 
AT (GAT) also called epididymal AT, mesenteric AT (Mes AT), omental AT, 
retroperitoneal AT, mediastinal AT and pericardial AT. 
If there is a positive energy balance, the role of WAT is to store lipids and avoid ectopic 
storage. A prolonged excessive energy intake, which exceeds energy expenditure, 
results in obesity which is defined as an enlargement of the fat mass detrimental to 
health (WHO definition). The World Health Organisation recognised that in 2016, 650 
million adults were obese (“WHO | Obesity and Overweight” 2018). A body mass 
index (BMI) superior to 30 kg/m2 is an indicator of obesity, however fat distribution 
is also an important factor, as measured by the waist to hip ratio (WHR). The “pear 
shape” characterises people with WAT accumulation around the hips (below the waist) 
while the “apple shape” is a central accumulation (above the waist). After being 
adjusted to the BMI, central WAT accumulation (or VAT accumulation in the 
abdomen), is more often associated with chronic diseases such as  type 2 diabetes and 
cardiovascular diseases (Matsuzawa et al. 1995; Fu, Hofker, and Wijmenga 2015). 
Indeed, the “Framingham Heart Study” gathered data of around 3000 people and 
showed a stronger correlation between VAT, compared to SAT, with different health 
risk factors, such as hypertension and increased fasting glucose (Fox et al. 2007; 
McLaughlin et al. 2011). As such, obese VAT has been at the centre of numerous 
studies. In humans the VAT is mostly represented by the omental AT (omentum). In 
comparison, mouse omental AT is a small tissue that only minimally store fat but have  
important immunological functions (Benezech et al. 2015; Jackson-Jones et al. 2016). 
The murine VAT studied during obesity is the GAT, as this is the one expanding the 
most with high fat diet (HFD) and linked with metabolic disorder (van Beek et al. 
2015).  
WAT responds to negative energy balance through lipolysis. Lipolysis is an enzymatic 
process by which AT releases the FFA contained in their lipid droplets to the 
bloodstream to accommodate organ energy demand. Indeed FA can be oxidised (FAO) 
by tissues to produce ATP (Stern, Rutkowski, and Scherer 2016; Duncan et al. 2007). 
How FFA are exported from adipocytes is not very clear yet, but fatty acid binding 
protein (FABP) 4 guide FFA to the plasma membrane for secretion (Nielsen et al. 
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2014). Insulin acts as an anti-lipolytic signal, favouring glucose uptake by tissues, by 
upregulating glucose transporters (GLUT) 1 and 4 (Stern, Rutkowski, and Scherer 
2016). Obesity is often associated with insulin resistance and elevated glycemia. Obese 
individuals have abnormally elevated basal lipolysis which results in elevated 
circulating FFA (Stern, Rutkowski, and Scherer 2016). But this is not the only lipid 
found to be in abnormal levels during obesity.  
1.2.2 Obesity, lipid metabolism and low grade inflammation 
The main dietary lipids found are TG, cholesterols, phospholipids (PL), 
cholesterols esters (CE) and FFA. FFA are brought to the tissue either directly as short 
chain, or in chylomicrons (CM) which are synthetized by enterocytes in the small 
intestine (Feingold and Grunfeld 2000). CMs gain the bloodstream via the lymphatics 
and once in circulation, go to the peripheral tissues where they are hydrolysed by 
lipoprotein lipases (LpL) in order to diffuse and be used by the cells (oxidation). The 
CM remnants (CMr), now richer in cholesterol as they lose TG, go back to the liver, 
which secretes in exchange very low density lipoproteins (VLDL) back to the 
circulation. The remnants VLDL are hydrolysed by the liver, to become low density 
lipoproteins (LDL) very rich in cholesterol and pro-atherogenic if in excess (Figure 
1.1). LDL are internalised via binding to the LDL-Receptor (LDL-R) at the cellular 
membrane before being hydrolysed into cholesterol in acidic organelles, called 
lysosomes. The transcription factor SREBP (sterol regulatory element binding 
proteins) will stimulate LDL-R synthesis when low levels of cellular cholesterol are 
detected (Horton, Goldstein, and Brown 2002). Finally, remaining cholesterol excess 
is returned to the liver by high density lipoproteins (HDL) in order to be excreted 
(Feingold and Grunfeld 2000; Jaishy and Abel 2016). 
Fifty to 60% of obese patients present dyslipidaemia (increased plasma levels of 
TG, LDL and VLDL and a decrease in HDL), and this represents a major risk factor 
for the development of cardiovascular disease (Feingold and Grunfeld 2000) 
(Mittendorfer 2011). Excess LDL and more generally hyperlipidaemia, can lead to 
lipid accumulation in arteries that cause fatty steak formation and atherosclerosis. 
Macrophages in these atherosclerotic plaques form lipid rich cells called foam cells 
and participate in inflammation (Moore and Freeman 2006). Additionally, the reduced 
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suppression of AT lipolysis and the increase in FFA coming from the diet results in 
elevated plasma FFA in obese individuals compared to lean subjects, which is linked 
with insulin resistance (Boden 2008). Lowering plasma FFA can restore insulin 
sensitivity (Boden 2008).  
 
Figure 1.1 Lipoproteins synthesis and use 
 
Obesity is also accompanied by a chronic low grade inflammation which favours 
the development of non-alcoholic fatty liver disease, type 2 diabetes and 
cardiovascular diseases, all factors linked with an increase in morbidity (Reilly and 
Saltiel 2017). The primary trigger of inflammation is uncertain and probably 
multifactorial. Pathological AT expansion, by hypertrophy or hyperplasia, is 
associated with increased apoptosis, increase release of pro-inflammatory cytokines 
such as IL-6 and IL1β and a toxic uncontrolled lipid spill over which can then 

















After a meal, enterocytes synthesize CM which quickly enter the blood circulation 
to be distributed to organs. The CM remnants go to the liver where they are used to 
create VLDL. VLDL in the circulation are used as energy or transformed as LDL. 
Excess lipids are brought to the adipose tissue to be stored as an energy source which 
can be mobilised when needed. Excessive levels of LDL in the blood can cause 
accumulation of foam cells in artery walls (atherosclerosis). CM: chylomicron; CM.r: 
chylomicron remnant; V : VLDL; L : LDL;LPL : lipoprotein lipases; FA: Fatty acid; 
TG: triglycerides 
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inflammation by binding toll like receptors (TLR) which promotes expression of genes 
involved in inflammation via the nuclear factor (NF) κB signalling pathway (Reilly 
and Saltiel 2017). Numerous studies mentioned a drastic upsurge of macrophages in 
AT that appear to be one driver of inflammation (Weisberg et al. 2003; M. T. A. 
Nguyen et al. 2007; A. A. Hill, Reid Bolus, and Hasty 2014; Ferrante 2013). The 
understanding of AT macrophage biology is still in progress and majorly linked to 
their role during obesity. First I will review some general knowledge about 
macrophage biology and then focus on adipose tissue macrophages (ATMs), as many 
elements can be transposed. 
1.3 Macrophage heterogeneity  
1.3.1 Recruited and resident macrophages  
The first description by Elie Metchnikoff of macrophages was simple: large 
cells (macro) capable of eating (phage). He described those cells as the “balayeur” 
(translated as “sweeper”), related to their great ability of phagocytosis (Metchnikoff 
1892). Traditionally, macrophages were designated as being exclusively derived from 
blood circulating monocytes coming from the bone marrow (BM) and entering the 
tissue (van Furth and Cohn 1968). Circulating monocytes are short lived and their 
number in the blood is dependent on the C-C chemokine receptor type 2 (CCR2). 
Indeed, Ccr2-/- mice have a drastic reduction in circulating monocytes, as they fail to 
exit the bone marrow upon CCL2/CCL7 (CC-chemokine ligand 2 and 7) mediated  
recruitment (Tsou et al. 2007). Those 2 chemokines (also known as MCP1 and MCP3), 
released by tissues, target inflammatory Ly6chigh monocytes to go to inflamed sites 
(Epelman, Lavine, and Randolph 2014a; Shi and Pamer 2011). Infiltrated Ly6c+ 
monocytes downregulate Ly6c and upregulate the major histocompatibility complex 
class II (MHCII) (Tamoutounour et al. 2012; C C Bain et al. 2013). In Human, 3 
subsets of monocytes are characterised using CD14 (LPS co-receptor) and CD16 
(FcγRIIIA): classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical 
(CD16++CD14+) monocytes (Geissmann, Jung, and Littman 2003). “Recruited” 
macrophages appear mainly during the innate phase of infection to fight pathogens 
with, notably, the production of proinflammatory factors (Helming 2011). However, 
characterising macrophages and macrophage role(s) in tissues and during infection led 
Chapter 1 Introduction 
 
 7 
to acknowledgement of their heterogeneity and notably the presence of tissue resident 
macrophages (Wynn and Vannella 2016). For instance, resident macrophages show a 
distinct gene expression profile compared to BM recruited macrophages, as well as 
distinct functions (Gundra et al. 2014). Resident macrophages play important roles 
during wound healing, resolution of inflammation, development, and maintain tissue 
homeostasis (Epelman, Lavine, and Randolph 2014b). In some cases, monocytes do 
participate in resident macrophage expansion in tissues, notably in the intestine, dermis 
and heart in a CCR2 dependent manner (Calum C Bain et al. 2014; Epelman et al. 
2014). However the origin of these residents cells in adult tissues has been shown to 
be more complex than the classical monocyte to macrophage transition as studies 
showed that macrophages can be maintained independently from the BM and have an 
intrinsic capacity to self-renew in tissues, notably dependent on IL-4 and colony 
stimulating factor 1 (CSF1) (Jenkins et al. 2011; Komornik 1985; Davies et al. 2011; 
Jenkins et al. 2013a). Recently, researchers emphasized the fact that macrophages from 
a tissue can have various origins but to determine this, distinguishing subsets is 
primordial (Shaw et al. 2018). Indeed, using CD4 and Tim4 as surface markers, they 
realised that the gut does have a subset of CD4-Tim4- macrophages highly dependent 
on the BM, while CD4-Tim4+ had a low dependency and the CD4+Tim4+ subset was 
maintained independently from the BM(Shaw et al. 2018). Interestingly, early during 
the course of inflammation, resident macrophages are partially depleted (known as the 
“disappearance reaction”), notably in the liver, the epidermis, the lungs and the 
peritoneal cavity. Surviving macrophages then go through a high proliferative activity 
to repopulate the tissue (Davies et al. 2013, 2011). During obesity, AT is considered 
as a site of sterile inflammation, raising the question of whether a disappearance 
reaction exists too. In the past decade, a paradigm shift occurred in the macrophage 
field as the embryonic origin of resident tissue macrophages was discovered, first in 
brain and epidermis (Davies and Taylor 2015). Macrophage tissue origin is a 
fascinating topic, and most tissues have their ontogeny covered, with the exception of 
ATMs which are still missing from major recent reviews (Hoeffel and Ginhoux 2015; 
Ginhoux and Guilliams 2016; Epelman, Lavine, and Randolph 2014b). However, we 
can still learn from these tissues to grasp an idea of the possible origin of ATMs.  
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1.3.2 Origin of tissue resident macrophages 
Method of study: generation of BM chimeras 
To understand the origin of tissue macrophages, during inflammation for 
example, BM chimeras can be generated. This method consists of the irradiation of a 
recipient/host followed by intravenous (iv) transplantation of histocompatible donor 
bone marrow, generally isolated from femurs. The donor’s cells re-populate the 
irradiated hematopoietic system and, after 2 to 3 weeks, leukocytes from the donor are 
detected in the host (Duran-Struuck and Dysko 2009). Total body irradiation uses a 
dose of gamma of about 9.5 Gray. A modified protocol includes the protection of body 
cavities from irradiation, inducing chimerism in blood monocytes, but sparing resident 
macrophage eradication (Aparicio-Vergara et al. 2010). Engraftment can then be 
followed over time: if the rates stay low, it is very likely that the macrophage 
population persists independently from the BM / blood monocytes. Other method of 
study exists, such as fate mapping, which are more relevant to understand embryonic 
origins of cells as I will describe in the following paragraph.  
Ontogeny 
M. Naito and K. Takahashi described immature macrophages (F4/80 “weak” and 
lacking phagocytic activity) by microscopy, localised in the blood islands of the 
embryonic mouse yolk sac (YS), a membranous vesicle attached to the embryo, at 
embryonic day 9 (E9) and the foetal liver (FL), which is the main hemopoietic organ 
in the embryo, at E10 (K. Takahashi, Yamamura, and Naito 1989). The first fate 
mapping studies showed that in the adult, brain macrophages (microglia) had a YS 
origin (Ginhoux et al. 2010) while Langerhans cells  (skin macrophages) were coming 
from the FL, with a minor participation of YS progenitors (Hoeffel et al. 2012). Later 
on, the embryonic origins of liver, spleen, lung and peritoneal macrophages were also 
confirmed (Yona et al. 2013). Typically, macrophages issued from the YS acquire a 
F4/80high (or bright) phenotype in contrast with HSC derived macrophages that are 
F4/80low (Schulz et al. 2012a). Most tissues retain pre-natal macrophages that persist 
in the tissue by proliferation. Nonetheless, these populations are replaced in a time, 
organ and sex dependent manner by HSC derived cells (Perdiguero and Geissmann 
2016). In a nutshell, macrophage generation in adults seems to be relying on either YS 
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erythromyeloid progenitors (EMPs), FL derived monocytes, or embryonic 
hematopoietic stem cells (HSC) (Gomez Perdiguero et al. 2014; Hoeffel and Ginhoux 
2015; Sheng, Ruedl, and Karjalainen 2015) (Figure 1.2).  
 
Figure 1.2 Three coexisting models of macrophage origin in adult tissues 
Three models of macrophage ontogeny have been hypothesised. Macrophages in 
adult tissue can originate from (1) YS EMPs (Gomez Perdiguero et al. 2014), (2) FL 
monocytes (Hoeffel and Ginhoux 2015), or (3) FL HSC (Sheng, Ruedl, and 
Karjalainen 2015). These embryonically derived macrophages persist in tissues by 
proliferation. HSCs are generated in the aorta-gonad-mesonephros (AGM) region 
prior to seed the FL. HSCs colonise the BM at E15, where haematopoiesis is detected 
from E17 and give rise to monocytes in adults mouse which will replace embryonic 
derived macrophages in a time and organ specific manner. 
 
1.3.3 Macrophage activation 
External stimuli can “activate” macrophages, skewing their response towards 
the synthesis of pro-inflammatory or anti-inflammatory cytokines. Macrophages are 
generally classified as M1 (classically activated) or M2 (alternatively activated). The 
M1/M2 nomenclature comes from older studies which defined macrophage 
populations based on their cytokine production, mainly done in vitro (Mackaness 
1962; Stein et al. 1992). M1 polarisation occurs when macrophages are stimulated with 
LPS or IFN γ. These macrophages produce pro-inflammatory cytokines (e.g.: IL-6, 
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M2 polarisation occurs when macrophages are stimulated with IL-4 or IL-13 which 
result in anti-inflammatory cytokine production such as IL-10 and TGF. M2 
macrophages promote tissue remodelling, angiogenesis and tumour growth (Martinez 
and Gordon 2014). From there, researchers described macrophages in tissues to be 
more M1 or M2 like and associate them with specific markers, which are still widely 
used in AT (Martinez and Gordon 2014). For example the M1/M2 markers applied by 
flow cytometry and fluorescence activated cell sorting (FACS) to ATMs are 
represented in the table below (Table 1-1) 
Table 1-1 M1/M2 markers associated with ATMs in mouse and human 
  ATM (pan markers) M1 M2 
Mouse 
Proteins 








Emr1 CD68  Tnfα; Il6; 
Ccl2, Nos2 










Genes  Mcp1; Tnfα ; Il10; Tgfβ 
Adapted from Hill et al. 2014 (A. A. Hill, Reid Bolus, and Hasty 2014) 
However, this convenient nomenclature does not reflect the real complexity of the in 
vivo biology. The entrance in the genomic era and the advance characterisation of 
macrophages in tissues shows that macrophages can indeed express both “M1” and 
“M2” markers (Davies and Taylor 2015).  
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1.4 Adipose tissue macrophages  
1.4.1 Maintaining a healthy AT: a balancing act for immune 
cells 
Healthy AT is home to various immune cells that act to remodel the tissue and maintain 
its functions. Lean AT contains anti-inflammatory (Th2-like) cells such as M2 
macrophages, eosinophils, T regulatory cells (Treg) and invariant Natural Killer T 
(iNKT) cells. They generally produce IL-10 which can repress tumor necrosis factor 
(TNF) α and control inflammation (Ferrante 2013). Discovered only recently in AT, 
iNKT  are present in the murine and human AT and maintain tissue homeostasis 
(Lynch et al. 2012). Obesity reduces their number in the tissue but restoring or 
activating them shows positive outcomes such as insulin and glucose sensitivity 
improvement (Lynch 2014). AT Foxp3+CD4+ Tregs express high levels of 
peroxisomes proliferator activated receptors (PPAR) γ compared to lymphoid organ 
Tregs. Their specific deletion inhibits drug-induced insulin sensitizing (Cipolletta et 
al. 2012). AT Tregs reduce AT inflammation and promote insulin sensitivity notably 
by their action on macrophages, adipocytes and T cells. Their loss, in obese AT, 
aggravates insulin resistance (Feuerer et al. 2009; Tiemessen et al. 2007). Eosinophils 
are important IL-4 producers, link to the promotion of M2 activation via the signal 
transducer and activator of transcription 6 (STAT6), the improvement of insulin 
sensitivity (Wu et al. 2011; Odegaard et al. 2007), but also the reduction of AT 
inflammation, decrease body weight and AT mass (Ricardo-Gonzalez et al. 2010). 
Surprisingly, helminth infection promotes eosinophilia and M2 macrophages in WAT 
and consequently improves metabolic function and notably, insulin sensitivity and 
glucose tolerance in HFD fed mice (Hussaarts et al. 2015). 
During obesity, the immune balance is disturbed and leans towards inflammation, 
notably with a “switch” of macrophage phenotype that I will further describe (Schipper 
et al. 2012; Ferrante 2013). Figure 1.3 summarises the principal changes in immune 
cells and cytokines produced during obesity.  
 




Figure 1.3 Immune cells in AT in lean and obese   
Lean AT contains various anti-inflammatory immune cells, such as eosinophils, 
resident macrophages, Th2 cells, Treg cells important for AT homeostasis. In obese 
AT, pro-inflammatory immune cells infiltrate the tissue and promote cytokines 
production that perturb AT functions. Adapted from Choe et. al (Choe et al. 2016).  
 
1.4.2 ATM roles and “switch” 
ATMs in lean AT promote insulin sensitivity notably because they are able to secrete 
IL-10, but also by removing dead cells and maintaining a healthy tissue (Osborn and 
Olefsky 2012; Lumeng, Deyoung, and Saltiel 2007). Macrophage infiltration in AT 
during obesity is one of the major elements occurring during the course of fat 
expansion (Weisberg et al. 2003). Most studies have focussed on ATMs in the context 
of obesity and on their pro-or anti-inflammatory properties. However, other beneficial 
roles for ATMs in the maintenance of AT homeostasis have more recently emerged 
(Figure 1.4)(Thomas and Apovian 2017). ATMs are involved in thermogenesis after 
cold exposure or β adrenergic stimulation, by promoting FA mobilisation in WAT and 
increasing uncoupling protein 1 (UCP1) gene expression (Wu et al. 2011; K. D. 
Nguyen et al. 2011; Qiu et al. 2014). ATMs promote adipogenesis and angiogenesis 
by secretion of platelet-derived growth factor and vascular endothelial growth factor. 



















Healthy AT AT dysfunction
NK cells
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(Martinez-Santibañez and Nien-Kai Lumeng 2014). Most importantly, recent studies 
showed a role for ATMs in the control of lipid efflux from AT, highlighting the fact 
that the net release of FFA from AT might rely on ATMs lipid buffering ability, which 
will be one of the axis of my thesis (Kosteli et al. 2010a; X. Xu et al. 2013; Boutens 
and Stienstra 2016). 
 
Figure 1.4 ATMs ensure tissue homeostasis 
ATMs are involved in lipid buffering, removal of dead cells, thermogenesis in beige 
subcutaneous adipose tissue, adipose tissue development and insulin sensitivity. Their 
presence ensures AT homeostasis.  
Usually, macrophages represent 5-10% of the stromal vascular fraction (SVF) in lean 
GAT, but can be multiplied by 5 in obese murine GAT, and by 3 in omental AT in 
human (from 4% to 12%) (Harman-Boehm et al. 2007; Ferrante 2013). Compared to 
lean AT, where ATMs are spread out in the tissue, during obesity, 90% of ATMs are 
regrouped around apoptotic or necrotic adipocytes, in what is called “crown-like” 
structures (CLS) (Figure 1.5). These structures appear in both mice and humans with 
obesity (Cinti et al. 2005; Murano et al. 2008; Bigornia et al. 2012).  




Figure 1.5 CLS in visceral AT in mouse (A) and human (B) 
Histological illustrations showing adipocytes surrounded by ATMs, forming CLS 
(indicated by arrows). A From Murano et al., 2008. Scale bar 50 µm B From Bigornia 
et al. 2012 (× 40).  
As just mentioned, the existence of two states in adipose tissue: lean non inflammatory 
and obese inflammatory led to the notion of ATM switch from M2 to M1 during 
obesity (C. N. Lumeng et al. 2008). Lean AT has increased expression of genes 
associated with an M2 signature such as Chi3l3, Arg1, Il10. In contrast, obese AT 
contains a subset of CD11c+ macrophages, associated with inflammation (Tnfα, Nos2) 
(Carey N Lumeng, Bodzin, and Saltiel 2007). Diphtheria toxin (DT) inducible 
depletion of CD11c+ cells in obese mice reduced inflammation and the recruitment of 
ATMs in the WAT and ameliorated insulin sensitivity (Patsouris et al. 2008b), thus 
revealing the role of inflammatory macrophages in the deregulation of insulin 
sensitivity during obesity. This raised the important question of the exact nature of 
these ATMs and their origin (recruited or resident).  
1.4.3 ATM Recruitment 
It was first shown in the early 2000s by Weisberg and colleagues, that in mice 
prone to obesity, a third of the transcripts coming from the GAT were genes related to 
macrophages, notably Csf1r (also known as CD115) and Cd68. By generating fully 
irradiated chimeric mice, they also showed that 85% of ATMs were coming from the 
BM (Weisberg et al. 2003). However, full irradiation compromises the tissue as it 
artificially increases recruitment as explained in 1.3.2. Following this important 
publication, researchers got interested in the mechanisms controlling macrophage 
recruitment in obese AT. MCP1  (CCL2) was shown to be elevated in murine obese 
BA
CLSCLS
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GAT (Kanda et al. 2006a). Similarly, in human, several other chemokines, including 
CCL2, were also found increased in the omentum and serum of obese patients (Huber 
et al. 2008). MCP1 is produced by a multitude of cells including adipocytes. When 
FFA arrive in AT, they trigger adipocyte TLR4 activation which initiates an 
inflammatory response, via NF-κB, and increases MCP1 expression by adipocytes 
(Reilly and Saltiel 2017). ATMs themselves can produce MCP1 via the same 
mechanisms (Catrysse and van Loo 2018). MCP1 receptor (CCR2) is expressed by 
monocytes and recruited macrophages (C. N. Lumeng et al. 2007). Recruitment of 
monocytes into tissues is CCR2 dependent and Ccr2-/-  mice exhibit a low monocyte 
count in their bloodstream, as they fail to exit the bone marrow to be recruited to tissues 
(Tsou et al. 2007). CCR2 recruited monocytes in AT are pro-inflammatory (M1). They 
express high level of IL-6, a pro-inflammatory cytokine. However, in Ccr2-/-   mice, 
ATMs are still present in the tissue, either as they rely on other recruitment signals or 
because they could be resident. These cells showed a distinct gene profile (M2-like) 
compared to the CCR2 recruited macrophages, the latter being more pro-inflammatory 
(C. N. Lumeng et al. 2007). This study pointed to the fact that ATMs might not all be 
CCR2 dependent.  
1.4.4 ATM Proliferation 
Recent studies showed that in addition to increased recruitment of BM derived 
monocytes, there is an in situ proliferation of ATMs during obesity. This was measured 
by 5-ethynyl-2′-deoxyuridine (EdU) injection, which labelled proliferating cells, 3h 
before the cull in mice fed with HFD for 7 weeks. EdU labelled 1% of the  
F480+CD11b+ cells (ATMs) in lean AT, whereas it labelled 4.5% in obese AT (Amano 
et al., 2014). They confirmed this proliferation data by using an intracellular staining 
of  Ki67, a protein expressed during mitosis. Another group strengthened these results 
and added that the IL-4/STAT6 pathway was one driver of ATM proliferation (Zheng 
et al. 2016a). Consistently across these publications, proliferating macrophages 
resided near CLS  (Amano et al. 2014; Zheng et al. 2016a). One study showed that 
these ATMs express M2 (CD206;CD301) rather than M1 markers and the authors 
found proliferative CD68+ ATMs in obese patients, located in CLS (Haase et al. 
2014a). The limitation of all these studies is that (i) the relative amount of recruited 
Chapter 1 Introduction 
 
 16 
and/or proliferative macrophages is hard to determine, (ii) macrophages are analysed 
as a whole and this does not take into account that ATMs may be heterogenous in 
terms of their BM dependency and their proliferative capacity. Therefore, there is still 
clearly a debate about ATM origin during obesity that this thesis will explore.  
1.5 Macrophages and lipid metabolism 
1.5.1 Lipid buffering properties of macrophages 
During fasting, lipolysis is increased to meet organ’s demand in energy. (Kosteli et al. 
2010b; Fitzgibbons and Czech 2016). Obese mice put on calorie restriction 
accumulated ATMs at day 3, which was quantified by CD68 and Emr1 (F4/80) gene 
expression, but was not associated with inflammation nor accumulation of pro-
inflammatory CD11c+ ATMs or CLS (Kosteli et al. 2010b). ATMs accumulated lipids 
in response to lipolysis, and became lipid laden, similarly to foam cell formation 
during atherosclerosis (Babaev et al. 1999). The authors highlighted a relationship 
between ATM content in GAT and FFA in the plasma of these mice, implying that 
fasting is linked with a surge in ATMs to respond to the increase in FFA efflux from 
AT. To support the buffering properties of ATMs, they transiently depleted 
macrophages via injection of clodronate encapsulated liposomes (i.p.) which increased 
FFA in the plasma. However, this technique ablates all macrophages, and by doing so 
it is not clear if all macrophages can buffer lipids or just a specific subset (Kosteli et 
al. 2010b). As mentioned in 1.2.1, basal lipolysis is also increased during obesity. 
Staining with Nile red after adherence on plates showed that ATMs can uptake lipids 
during HFD (C. N. Lumeng et al. 2007). Two other studies demonstrated that, contrary 
to fasting, CD11c+ ATMs  accumulated during HFD feeding and have the highest lipid 
content when compared to CD11c- ATMs. CD11c+ ATMs represent, in some cases, 
33% of ATMs in the tissue of obese mice, and assessing all CD11c- ATMs together 
(67% of all ATMs) might mask a potential subset that would be more efficient than 
CD11c+ cells at picking up lipids (Prieur et al. 2011; Grijalva et al. 2016). There is 
thus an urgent need to acknowledge ATM heterogeneity of function.  
Xu et al. move the concept forward by hypothesising that lysosomal lipolysis (the 
hydrolysis of TG in FFA by the lysosomal acidic lipase, LAL) in ATMs played an 
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important role in lipid trafficking (Figure 1.6). To test this, they used chloroquine, a 
strong inhibitor of lysosomal acidification which impairs LAL activity and thus stop 
lipid degradation (Emanuel et al. 2014). Chloroquine increased the lipid content in 
BM-derived-ATMs in vitro, and when added to obese AT explants, FFA efflux in 
media was decreased. First, they concluded that AT lipolysis was ATM dependent. 
The same observation was observed in vivo with decrease of serum FFA after injection 
of chloroquine in obese mice. This action was totally reversed when macrophages were 
depleted using clodronate liposomes (X. Xu et al. 2013). They concluded that there is 
an increased lysosomal activity in ATMs to buffer lipids that are released from 
apoptotic adipocytes during obesity. However the origin of these lipids was only 
hypothetical and could be expanded to lipids from the circulation. Moreover, in their 
model, all macrophages were depleted using chlodronate. Importantly, the authors 
highlighted that lysosomal activation was not linked with a M1 ATM polarisation state 
like during obesity (X. Xu et al. 2013). It is thus possible that macrophage origin 
(recruited vs resident) dictates macrophage lipid handling, one being more 
metabolically inclined to degrade lipids by fatty acid oxidation (FAO) for example. 
Also, ATMs contained in CLS can liberate lysosomal enzymes by exocytosis to pre-
digest adipocytes needed to be phagocytised and be a source of lipids (Haka et al. 
2016). 
 
Figure 1.6 ATM lysosomal activity control lipid efflux. 
Obese adipose tissue release lipids that can be buffered by ATMs. A short 
inhibition of lysosomal activity using chloroquine blocks lipid catabolism, induces 
lipids retention in ATMs, and decreases FFA efflux in the circulation. Adapted from 
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1.5.2 Intrinsic lipid metabolism and lysosomes  
Experiments in which BM macrophages were polarised toward M2 or M1 
demonstrated that the energy need of M2 and M1 are highly different and that their 
polarisation requires a different type of metabolic adaptation. Indeed, M2 rely heavily 
on FA uptake and their oxidation in the mitochondria, while M1 favour glycolysis 
(O’Neill, Kishton, and Rathmell 2016). In M2, FA are obtained by hydrolysis of TG 
rich lipoproteins such as CM, LDL and VLDL. The scavenger protein CD36, located 
at the macrophage’s surface, internalised TG which are catabolised by LAL in 
lysosomes as described by Xu et al. (S. C.-C. Huang et al. 2014). CD36 dependent TG 
uptake leads to increased oxidative phosphorylation (OXPHOS) rates. Blocking with 
orlistat, a lipase inhibitor, decreases lipolysis and OXPHOS, and leads to a marked 
reduction of M2 markers (such as CD206, CD301 and RELMα), indicating that M2 
polarisation is dependent on lipid oxidation (Heck, Yanovski, and Calis 2000). 
Targeting LAL induce lipid accumulation in M2 and decreased FAO, as measured by 
a decrease in oxygen consumption rates (SeaHorse technology) (S. C.-C. Huang et al. 
2014).  
Lysosomes are abundant and active in ATMs from obese mice. They accumulate in 
lipid laden macrophages, and do not corelate with a M1 phenotype (X. Xu et al. 2013). 
A recent publication acknowledge that there rather is a “metabolic activation” of 
ATMs during obesity, that does not resemble M1 or M  activation (Boutens et al. 
2018). Interestingly, ATMs contained in CLS upregulate glucose transporter (GLUT) 
1 (Appari, Channon, and McNeill 2018). Micro-array analysis of ATMs revealed that 
during obesity, ATMs showed an enrichment for set of genes involved in carbon 
metabolism (glycolysis) and OXPHOS (Boutens et al. 2018). Although, this could 
indicate that different types of ATMs coexist, and this is not as simple as ATMs 
switching from M2 to M1. The field is thus starting to move forward. In addition, work 
in the branch of atherosclerosis can give us some insight in the mechanism regulating 
lipid cellular metabolism in ATMs. 
Foam cell formation 
Little is known about foam cell biology in ATMs but atherosclerosis has been more 
largely studied. In atherosclerosis, macrophages uptake lipoproteins from the plaque 
Chapter 1 Introduction 
 
 19 
and its environment, notably oxidised LDL (oxLDL). LDL oxidation is promoted by 
free radicals, 12/15-lipoxygenase (LO), and myeloperoxidase present in the arterial 
wall. Tissue macrophages express scavenger receptors such as SR-A, LOX1, MARCO 
and CD36 and can internalise and hydrolyse oxLDL in their lysosomes (Kunjathoor et 
al. 2002). Lysosomes are guarantor of the degradation of vesicles coming from 
phagocytosis (Jaishy and Abel 2016; Lim and Zoncu 2016). They contain proteases, 
nucleases and lipases, enabling the digestion a wide range of molecules, including 
lipids. After lysosomes catabolise lipoprotein into free cholesterol and FFA. FFA are 
ligands of peroxisomes proliferator activated receptors PPARs (α, γ, δ). In vitro 
activation of PPARs results in a rise in cholesterol efflux via increasing the number of 
ABCA1 transporters (Rader and Puré 2005). Indeed, cellular free cholesterol can either 
exit macrophages via these ABCA1 transporters, or traffic to the endoplasmic 
reticulum (ER) to undergo modifications and form cholesteryl esters (CE) (Figure 1.7) 
(Jeong, Lee, and Oh 2017). CE are packaged into lipid droplets that can be hydrolysed 
via creation of autophagosomes, which are fused to lysosomes and hydrolysed by 
LAL. The free cholesterol can then also exit via ABCA1 transporter (Emanuel et al. 
2014). During the progression of atherosclerosis and diabetes, lipids are in excess and 
more lipid droplets accumulate in the macrophage, but also into dysfunctional 
lysosomes, which give its “foamy” appearance  to the macrophage (Ouimet et al. 
2011).  




Figure 1.7 Lipid metabolism in macrophages of the atherosclerotic plaque 
Uptake of lipids and lipoproteines occurs via multiple receptors. Once in the 
macrophage, the lipid microparticles are degraded by the lysosomes into free 
cholesterol and FFA for ABCA1- dependent efflux. Free cholesterol traffic to the ER 
where it is esterified into CE and packaged into lipid droplets. Lipid droplets are 
integrated into autophagosome which fuse with lysosomes to be degraded into free 
cholesterol and FFA which can exit the cell (lipid efflux). Accumuation of CE in the 
macrophage give it its foamy appearance characteritic of the progress of 
atherosclerosis. Adapted from Moore, Shedy and Fisher Nat Review Immunology 
2013 
 
It is possible that saturation of lysosomal lipolysis in ATMs leads to the formation of 
foam cells which become more inflammatory. Thus, there is a real importance of 
studying ATM metabolism to understand obesity, lipid and meta-inflammation. 
Interestingly, a receptor expressed on murine macrophages and dendritic cells has been 
linked in numerous studies with dyslipidaemia in human (Kathiresan et al. 2009b; 
Weissglas-Volkov et al. 2013). However the study of this receptor regarding metabolic 
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1.5.3 Timd4, gene coding for phosphatidylserine receptor on 
macrophages is associated with dyslipidaemia  
The phosphatidylserine receptor Tim4 (T-cell immunoglobulin and mucin domain 
containing protein 4), is present on macrophages of various tissues including spleen 
macrophages, Kupffer cells in the liver and the resident large peritoneal macrophages 
(Rosas et al. 2014; Davies and Taylor 2015). When cells die, they expose their 
phosphatidylserine (PS) on their surface. This “eat me” signal is recognised by Tim4 
macrophages for their engulfment (Miyanishi et al. 2007). The “Tim” family plays a 
role in immune regulation , notably in allergy, asthma and autoimmunity (Freeman et 
al. 2010). It contains 8 members (Tim1-8) in mouse and 3 in human. The murine Tim4 
is an orthologue of the human Tim4. The Tim structure is made of an N 
immunoglobulin-like extracellular domain, a mucin domain, a transmembrane domain 
and a cytoplasmic region. The extracellular domain binds PS via a metal ion-dependent 
ligand-binding site (Santiago et al. 2007). This part of the interaction in hydrophilic, 
while the fatty acid and glycerol composing the rest of the PS interact with 
hydrophobic residues on Tim4. The engulfment mediated by Tim4 is an ATP 
dependent process (Park, Hochreiter-Hufford, and Ravichandran 2009). Tim4+ and 
MerTK+ (myeloid-epithelial-reproductive tyrosine kinase) are required for the correct 
engulfment of apoptotic bodies by peritoneal macrophages. Tim4 acts as a tethering 
receptor and if blocked, the engulfment process is drastically reduced (Nishi et al. 
2014). Tim4 resident macrophages in the peritoneal cavity synthesise the enzyme 
12/15-lipoxygenase (12/15-LO) which directs the uptake of apoptotic cells towards 
Tim4+ macrophages themselves and block their uptake by inflammatory monocytes, 
indicating a key regulatory role for these macrophages in the control of phagocytosis 
(Uderhardt et al. 2012). The 12/15 LO can oxidase lipids such as LDL, but no link yet 
has been made between Tim4 and oxLDL uptake or any other lipids. Interestingly, 
TLR4 activation (which can act with CD36 to uptake lipids) promotes Tim4 expression 
(Ji et al. 2014). As said, TIMD4, the gene coding for Tim4, is found in humans. 
Genome-wide association study (GWAS) showed association of TIMD4 (5q23 loci) 
with blood LDL cholesterol in multiple studies, reviewed in Table 1-2 (Weissglas-
Volkov et al. 2013; Kathiresan et al. 2009a; Spracklen et al. 2017; Surakka et al. 2015; 
Teslovich et al. 2010; Willer et al. 2013). However, these studies do not mention if the 
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single nucleotide polymorphisms (SNPs) found in the gene modify the protein 
structure or function. In human, Tim4 macrophages are present in the spleen and tonsil 
(Kobayashi et al. 2007). But there is no reported studies of human Tim4 ATMs. 
Table 1-2 Genome wide association study involving Timd4 
Single nucleotide polymorphisms (SNPS) reported in the chromosome 5, region 5q33.3, 
corresponding to Timd4 have been associated in several studies with traits such as 
cholesterol, LDL, triglycerides, hypertriglyceridemia. The P-value indicates the genome 
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Contrary to other Tims, Tim4 does not contain tyrosine phosphorylation motif and 
little is known about the intracellular signalling of this receptor (Freeman et al. 2010). 
Despite the fact that the study from Park in 2009 showed that Tim4 doesn’t have a 
direct signalling pathway, other studies mention an intracellular interaction between 
Tim4 and AMPKα1 (Park, Hochreiter-Hufford, and Ravichandran 2009; Baghdadi et 
al. 2013). Interestingly, AMPKα1 signalling promote M2 activation, reduce the 
production of pro-inflammatory cytokines by macrophages and a global KO of 
AMPKα1 enhance lipid accumulation in adipocytes suggesting a role of AMPKα1 in 
lipid metabolism (W. Zhang et al. 2012). Indeed AMPK activates FAO in cells, 
indicating that Tim4 macrophages could oxidise lipids (Jeon 2016). The GWAS 
directed the interest of a team towards Tim4 blockade in atherosclerosis, pathology 
linked with high level of LDL in the plasma. They showed that in ldlr-/- mice fed for 4 
weeks with HFD, blocking Tim4, aggravated atherosclerosis as apoptotic cells 
accumulates in the lesion and the blood, but also increased the proportion of activated 
T cells in the bloodstream (Foks et al. 2016). This is the only study, to my knowledge, 
studying the role of Tim4 in the setting of dyslipidaemia. Tim4 macrophages are 
present in the peritoneal cavity on F4/80high “large” resident population (Rosas et al. 
2014; Davies and Taylor 2015), but are also resident in the liver (Kupffer cells) and 
the gut (Scott and Guilliams 2018; Shaw et al. 2018). At the onset of this PhD, it has 
not been established if Tim4+ macrophages exist in AT (of human and mouse) and if 
they could play a role in the control of lipid homeostasis which could explain the traits 
found in GWAS. 
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1.6 Thesis aim and hypothesis  
Defining the origin and the heterogeneity of ATMs is key to identify potential targets 
against tissue inflammation and dyslipidaemia that occurs during obesity or HFD 
stress. My overarching hypothesis is that ATMs are an heterogenous population and 
that it encompasses populations of macrophages with various functions particularly 
regarding lipid uptake and catabolism. 
Therefore, this thesis aims to characterise and phenotype ATM subsets in order to 
better understand their potential specific role in the tissue in lean (Chapter 3) and obese 
(Chapter 4) AT. During the course of this research, a novel population of Tim4+ 
resident ATMs was identified. An additional aim of this thesis is thus to elucidate the 
role of Tim4+ ATMs and Tim4 in adipose tissue homeostasis (Chapter 5). Finally, the 
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2.1 In vivo experiments 
2.1.1 Animal 
All animal experiments were carried out in accordance with the Animal (Scientific 
Procedures) Act, UK 1986 following approval by the University of Edinburgh Animal 
Ethical Review Committee and Vets through Experimental Request Forms. Mice were 
housed in standard cages (except stated otherwise) and given food and water ab 
libitum. 
2.1.2 Time course experiments 
C57BL/6J pups, bred in house, were taken and culled by neck dislocation.  
2.1.3 HFD experiments  
6-8 week old C57BL/6J males were put on a control diet (CD) (11kcal%Fat and corn 
starch, Research diet, D12328i) or a high fat diet (HFD) (58Kcal%Fat and sucrose, 
Research diet, D12331i) for variable periods of time (from 1 day to 14 weeks). 
2.1.4 Oral glucose tolerance test (OGTT) 
After 8 weeks of CD or HFD, mice were given a bolus of glucose to test their glucose 
tolerance. Mice were fasted from 5-6 hours and put in the room where the OGTT was 
conducted to limit stress. First basal fasting glucose was measured after blood was 
taken by venesection. To read the measure, a commercially available glucometer was 
used (Roche, Accu-Chek Performa Nano). Then mice were given a bolus of glucose 
by gavage (2g/kg body mass) and blood was sampled at 15, 30,60 and 120 minutes 
post-glucose to read the level of glucose.  
2.1.5 Generation of chimeras 
General 
Protected/partial bone marrow irradiation was realised in collaboration with Dr 
Stephen Jenkins and his team following a protocol they developed (Centre for 
Inflammation Research, Queen’s Medical Research Institute, Edinburgh). First, mice 
were sedated/anaesthetised and the upper half of the body (head, thorax and front set 
of legs) exposed to lethal levels of gamma-irradiation (12Gy) for 19 min 30 seconds. 
Mice were irradiated on a Perspex sheet over laying a 2 inch thick block of lead, with 
Chapter 2 Material and methods 
 
 27 
only the upper half (or the lower half) of the body uncovered, this for the maximum 
protection of the adipose tissue. After irradiation, the mice were injected s.c. with 
antisedan to reverse the sedation, and keep in a warm cage (30°C) up until awareness 
was found again. Then they were randomly put in individually ventilated cages (5 by 
cage). The next day, mice received 2 to 5 millions donor bone marrow cells iv obtained 
in house. Mice were kept on mash for 2 weeks then put back on normal diet for 2 
weeks. They received baytril for 4 weeks following irradiation to limit infection.  
Chimeras and macrophage origin   
Eight weeks old C57BL/6J Ly5.1 female mice were partially irradiated as described 
in 2.1.5. Mice were reconstituted after radiation with congenic CD45.2+ WT BM or 
Ccr2-/- BM obtained in house. After 8 weeks’ recovery, the gonadal and mesenteric 
adipose tissue were collected for flow cytometry analysis (Figure 2.1). Irradiations 
were conducted by Dr Stephen Jenkins lab. 
 
Figure 2.1 Experimental design of partial BM chimeras  
After irradiation of the head, Ly5.1 host females (expressing CD45.1 and CD45.2), 
were injected i.v. with CD45.2+ donor BM or Ccr2-/- BM. After recovery, mice were 
then put on a control diet or a HFD (60% fat) for 8 weeks.  
 
Chimeras and HFD  
Eight weeks old Ly5.1 male and female mice were partially irradiated as described in 
2.1.5, and reconstituted with congenic CD45.2+ WT BM. After 4 weeks of baytril and 
mash + normal diet, mice were put on either a control diet (11kcal%Fat and corn 
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starch, Research diet, D12328i) or a HFD (58Kcal%Fat and sucrose, Research diet, 
D12331i). After 8 weeks of diet, mice were sacrificed by exsanguination under 
terminal anaesthesia (Figure 2.2). Irradiations were conducted by Dr Stephen Jenkins 
lab.  
 
Figure 2.2 Experimental design of partial BM chimeras coupled with diet to study 
macrophage turn-over during HFD. 
After irradiation of the head, Ly5.1 host mice (expressing CD45.1 and CD45.2), both 
males and females, were injected i.v. with CD45.2+ donor BM. After recovery, mice 
were then put on a control diet or a HFD (60% fat) for 8 weeks.  
 
2.1.6 In vivo Tim4 blockade 
Mice were i.p. injected with 100µl of PBS containing either 200ng of monoclonal 
antibody anti mouse Tim4 (aTim4) (clone RMT4-53, Rat IgG2a, BE0171 from 
BioXCell) or 200ng of of rat IgG2a isotype control (Isotype) (BE0089 from BioXcell). 
These concentrations were based on a publication from 2016 (Foks et al. 2016). The 
experiments coupled with HFD were performed as shown in Figure 2.3 




Figure 2.3 Experimental design of Tim4 blockade during long (A) and short HFD 
(B) 
Male mice were given a HFD for 8 weeks (w: weeks) or for a shorter period of time 
(D: day). A After 4 weeks of diet, mice from both groups were i.p. injected twice a 
week for the rest of the experiment with 100µl of PBS containing either 200ng of 
blocking anti-Tim4 IgG2a or 200ng of isotype IgG2a control (plain arrow). An oral 
glucose tolerance test (OGTT) was performed 2 to 3 days before the cull. B Short HFD 
with injection of 100µl of PBS containing either 200ng of blocking anti-Tim4 IgG2a 
or 200ng of isotype IgG2a control (plain arrow) 
 
2.2 Cell isolation 
2.2.1 Human adipose tissue 
Omentum or SAT were collected by surgeon in PBS. Shortly after collection ,tissues 
were digested using the gentleMACS dissociator (Miltenyi Biotec). Tissues were put 
in tubes containing 5ml of PBS BSA 2% and collagenase I (2mg/ml) (Worthington 
LS004196), and after mechanical dissociation, were incubated in a water bath at 37°C 
for 30 minutes, with a shake after 15 minutes. The reaction was stopped by using 25µl 
of EDTA (0.5M). After filtration (100µm), tubes were spun at 700g for 10 minutes at 
4°C to dissociate adipocytes from the stromal vascular fraction.  
2.2.2 Murine adipose tissue 
Adipose tissue were harvested in RPMI and kept at room temperature. Shortly after 
the harvest, the tissues were weighed and put into the digestion media (Collagenase D 
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10mg/ml in RPMI 1% FCS) (500µl/tubes). Each tissue was pre-cut with scissors to 
facilitate the collagenase digestion, and put at 37°C for 30 minutes to 45 minutes. A 
gentle mixing with pipetting up and down a few times after 15 minutes of incubation 
was done. At the end of the incubation, EDTA (50mM) was added to the digests 
(5µl/ml) to stop the enzyme by ion chelation. RPMI 1% FCS was added on top and 
the digests were filtered (100µm – 75 µm) and centrifuged at 700g for 10 minutes at 
4°C in order to separate the stromal vascular fraction (SVF ; containing leukocytes, 
pre-adipocytes, fibroblasts) from the floating fraction (containing mainly adipocytes) 
. If the floating fraction was needed, the centrifugation was done at room temperature 
to avoid it to freeze. After separation, cells from the SVF was counted in 2 ml of RPMI 
1% FCS with the Biorad cell counter.  
2.2.3 Peritoneal cavity lavages 
In order to retrieve the cells of the peritoneal cavity, mice were euthanised in a CO2 
chamber. Quickly following death, 2ml of RPMI was injected in the cavity of 
C57BL/6J mice. After a short shake of the cavity, the media was taken back and put 
in falcon tubes on ice. Cells were then spun at 1200g for 5 minutes at 4°C. The pellet 
contained immune cells for further analysis.  
2.2.4 Liver 
Livers were perfused with PBS to eliminate blood from vessels, and put on a tube on 
ice. Using a razor blade, livers  were chopped in small petri dishes with a few drops of 
RPMI up until full homogenisation. Then, they were put in a 50ml Falcon tube with 
the cocktail of enzyme described in Table 2-1 prepared in warm RPMI (5ml per liver). 
The Falcons were placed in a water bath at 37°C for 22 minutes, with vigorous shaking 
every 5 minutes. At the end of the 22 minutes, cold RPMI (30ml) was poured on top 
of the liver digest and the mixture was filtered (100µm filter). Tubes were spun at 300g 
for 5 mins, 4°C. For better results, a second filtration was done with a 70µm filter after 
cell resuspension in 30ml of RPMI. Tubes were spun again at 300g for 5 mins and the 
digests were resuspended in 5 to 10 ml and cells were counted. 
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Table 2-1 Enzymes necessary for liver murine liver digestion 
Enzyme Concentration Suppliers 
Collagnease V 0.8mg/ml Sigma Cat. No. C9263-1G 
Collagenase D 0.625mg/ml Roche Cat. No. 11 088 882 001 
Dispase 1mg/ml Gibco Cat. No 17105-041 
DNase 30mg/ml Roche Cat. No. 101 104 159 001 
 
2.3 In vitro experiments  
2.3.1 Fatty acids dosage 
Samples of blood were taken from a brachial exsanguination in tubes (BD Vacutained) 
and spun at  1800g for 10 minutes to separate the plasma from the rest. FFA was 
measure using a WAKO Kit ( reagent 1 : 434-91795; reagent 2: 436-91995) and 
WAKO standard (4270-77000). A slightly modified protocol was used:  
- Add 10µl of plasma in wells after gentle mixing to homogenise the sample 
- Add of 150µl of reagent 1 for 3minutes (at 37°C) 
- Add 75µl of reagent 2 for 4 minutes (at 37°C) 
- Reading at 546nm and 660nm  
 
2.3.2 Adhesion mediated purification of macrophages  
Cells obtained from AT, PEC or liver were resuspended in serum free RPMI and  
placed on a 24 well plate, up to 500 000 cells per well for AT and PEC, 1 million for 
the liver (due to the fact that more cells (non-macrophages) are in the digests compared 
to the other tissues). Each well contained a 13 mm coverslip to be able to analyse the 
cells later by microscopy. After 30 minutes to 1h at 37°C in 5% CO2, the cells were 
washed in RPMI (room temperature) 3 times. Macrophages are able to adhere to the 
coverslip, and other cells are washed away (Davies and Gordon 2005).  
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2.3.3 In vitro LDL uptake by macrophages 
After adhesion mediated purification of macrophages, 300µl of media containing  
50ng anti Tim4 or Isotype control for 30 minutes to 1h, then LDL-Bodipy (Invitrogen 
BodipyTM FL low-density lipoprotein, 50ng/ml) was added. After 6 hours, lysotracker 
(DND99) was added (500nM) for 30 minutes at 37°C to stain the lysosomes. The 
coverslips were washed 2 times in PBS and fixed with 2-5% NBF for 10 min at RT.  
2.3.4 Chylomicron uptake by macrophages  
After adhesion mediated purification of macrophages, 300µl of media containing  
50ng anti Tim4 or Isotype control for 30 minutes to 1 hour, then chylomicrons (Human 
plasma CM, CMIC15-N from Alpha Diagnostic, 83µg/ml) was added for 3 hours. 
Before the end of the incubation, Lysotracker (DND99, 500nM) was added for 30 
minutes at 37°C to stain the lysosomes. The coverslips were washed 2 times in PBS 
and fixed with 2-5% NBF for 10 min at RT.  
2.4 Techniques of analysis 
2.4.1 Flow cytometry 
Staining 
Cells were plated in 96 well plate and the staining was realised in a total volume of 
50µl/well. If no intracellular staining was required, the cells were stained in 2 steps 
(on ice):  
• 10 minutes in blocking buffer (25µl per well) 
• 30 minutes in antibody mix (25µl per well), made in FACS buffer  
• Wash 2 times in FACS buffer and resuspend in 200µl of FACS 
• Add 2µl of DAPI before flow acquisition (Sigma Aldrich;1mg/ml stock) 
 
If fixation and/or intracellular staining was needed, the following steps were followed 
for each samples: 
• 10µl of Live/Dead (Thermofisher) diluted in PBS, 10 minutes at room 
temperature in the dark  
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• 15µl of blocking buffer for 10 minutes on ice  
• 25µl of antibody mix 
• Wash 2 times in FACS buffer  
• Fixation/permeabilization 1 hour (eBioscience) or fixation with 5% NBF for 
10 minutes followed by permeabilization (eBioscience) 30minutes and intra-
cellular staining in permeabilization buffer. 
Samples were acquired using a BD LSR 5 Fortessa and analysed with FlowJo software 
(Tree Star).  
Table 2-2 List of buffers 
BUFFER NAME COMPOSITION Manufacturer 
Blocking buffer 1x FACS Buffer 
20% rat and mouse serum  
FcR CD16/32 (1/300)  
 
Biolegend 
10x FACs Buffer 50 ml of PBS 
2.5g Bovine Serum Albumin 
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2.4.2 Gating strategy 
Bone marrow chimeras  
 
Figure 2.4 Gating strategy used to define immune cells in the GAT after 
generation of BM chimeric mice.  
After generation of BM chimeras as decribed in 2.1.5, GAT and MES imune cells were 
analysed by flow cytometry and imune subsets were gated as presented (A). To define 
the non-host chimerism, cells were gated on CD45.2+ cells as shown in B. 
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M1/70 Rat IgG2b Biolegend 0.2 mg/ml 1/1200 
CD11c  BV605 N418 Armenian 
Hamster IgG 
Biolegend 0.2 mg/ml 1/200 
CD19 BV421 6D5  
Rat IgG2a 
Biolegend 0.2 mg/ml 1/200 
CD206  FITC MCA2235
FA 
Rat Miltenyi  1/200 
CD45.1 PE/Cy7 A20 Mouse IgG2a Biolegend 0.2 mg/ml 
 
 1/200 
CD45.2 BV650 104  
Mouse IgG2a 
Biolegend 0.2 mg/ml 
 
1/200 
F4/80  PE/Cy7 BM8 Rat IgG2a Biolegend 0.2 mg/ml 
 
1/200 
KI-67  FITC  REA183  recombinant 
human IgG1 











Ly6C  AF700 HK1.4 Rat IgG2c Biolegend 0.5 mg/ml 1/200 
Ly6G BV421 1A8  
Rat IgG2a 









Rat / IgG2b ebiosciences 0.2 mg/ml 
 
1/600 
Siglec F BV421 E50-2440 Rat LOU BD 0.2 mg/ml 1/200 
TCRb BV421 h57-597 Armenian 
Hamster IgG 
Biolegend 0.2 mg/ml 1/200 
Tim4 PE RMT4-54 Rat IgG2 ebiosciences 0.2 mg/ml 1/1200 
Lysotra-





 ThermoFisher 1mM 1/1500 
 




Figure 2.5 Gating strategy used to define macrophages in human visceral AT 
(omentum).  
Flow cytometry plots showing the gating strategy used to define ATM in human. 
Macrophages were gated on Live cells (DAPI negative), singlets, CD45+, CD15-Lin- 
CD11b+ cells then divided according their CD16 and CD14 expression. 
Table 2-4 Flow cytometry antibody clones, manufacturer and titration (human) 
Antigen 
Name 
Conjugate Clone Manufacturer Isotype Titration 
CD14 e 450 HCD14 Biolegend Mouse IgG1 1/25 
CD163 BV605  Biolegend Mouse IgG1 1/20 
CD45 BV650 HI30 Biolegend Mouse 
IgG2a 
1/20 
Tim4 PE/Cy7  9F4 Biolegend Mouse IgG1 1/10 
HLA-DR FITC L243 Biolegend Mouse IgG2 1/20 











W6D3 Biologend Mouse IgG1 1/40 
CD62L PerCPcy55 DREG-
56 
Biolegend Mouse IgG1 1/20 
CD16 BV711 3G8 Biolegend Mouse IgG1 1/20 
CD11b AF700 M1/70 Biolegend Rat IgG2b 1/200 
CD64 APCcy7 10.1 Biolegend Mouse IgG1 1/20 
CD206 AF647 15_2 Biolegend Mouse IgG1 1/20 
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2.4.3 Cell sorting and cytospin  
Cells were stained as described in 2.4.1. Cells were then sorted (FACS ARIA) in tubes 
containing RPMI complemented with 10% FCS. 100µl of the cell suspension were 
transferred to a cytocentrifuge cytofunnel containing a slide and a filter card. Cells 
were cytospined for 3min at 300g onto the slide (X. Zhang, Goncalves, and Mosser 
2008). Shandon™ Kwik-Diff™ (Thermofisher) staining solutions was used to stain 
the cells according to the manufacturer’s instructions.  
2.5 Microscopy 
2.5.1 Whole mount immunofluorescence staining for confocal 
microscopy  
The samples were fixed in 10% neutral buffered formalin (NBF, Sigma) for 2 hours 
on ice then transferred in PBS. The tissues were cut in smal pieces to facilitate the 
staining and the mounting. The staining was realised in 3 steps: 
• Permeabilization with Triton 1% (Sigma) for 30 min * 
• Antibody mix in 1%Triton*/PBS BSA 1% (1:1) for 2 hours on a shaking plate 
(room temperature) or overnight at 4°C 
• Wash 3 times in PBS 
*To visualise lipids or lysosomes in macrophages, triton 0.1% or no triton at all was 
added. 
The tissues were mounted in a mounting media (Fluoromount, Sigma Aldrich) as 
shown in Figure 2.6 (Wang, Scherer, and Gupta 2014).  
 
Figure 2.6 Mounting of tissue for microscopy analysis  
The tissues were place in the middle with mounting media. Vaseline was placed 
and a coverslip was added on top. To seal the coverslip, nail varnish was added around, 
or in some cases superglue.  
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The antibodies used for immunofluorescence microscopy are listed in the table below  
Table 2-5 Antibodies used for immunofluorescence staining   
Antigen Name Conjugate Manufacturer Titration 
Tim4 anti mouse APC Biolegend 1/50 
CD11b PB Biolegend 1/200 
Anti-rat IgG AF 647 Invitrogen 1/400 
Tim4 anti human APC Biolegend  1/50 
Lysotracker RED ThermoFisher 75 to 500nM  
 
2.5.2 Lysotracker and LipidTox staining  
Lysotracker staining. Lysotracker red (577/590; Lysotracker red DND99 from 
TermoFisher) was used on live cells (500nM) and tissues (1/1000). The dye was 
diluted in warm RPMI, and put with the cells/tissues for at least 30 minutes. Then the 
tissues were fixed in formalin neutral buffer (10%) followed by wholemount staining. 
The cells were fixed in formalin neutral buffer 2-5% and kept in PBS in the fridge for 
following staining.  
LipidTox staining. HCS LipidTox Green Neutral lipid stain from Invitrogen was used 
to stain neutral lipids after fixation. If used on cells the concentration was of 1/500 and 
on tissues 1/100. Permeabilization reduced the dye intensity, so only a gentle 
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2.5.3  Fiji analysis  
Intensity measurement in single cell 
In order to analyse the intensity of lysotracker and lipid content for each cell, I created 
a macro to run on FIJI, a free image processing software:  





run("Analyze Particles...", "size=10-Infinity display exclude clear add in_situ"); 
  
The first step included the duplication of the channel 4 (with Tim4 APC staining), then 
the identification and count of positive cells, and to finish the measurement of 
fluorescence intensity. The threshold to identify Tim4+ macrophages was defined on 
the first image and was not changed. The lysotracker and lipid intensities were 
measured on raw images, with no change of threshold or image modification (Figure 
2.7).  
 




Figure 2.7 Example of automatized measurement of lysotracker and lipid 
intensity using FIJI 
After taking images using the LEICA SP5 microscope (x40) (A), images were 
analysed using FIJI software (B). The macro created in FIJI (bottom panel), allowed 
to select Tim4+ cells, according to a set Threshold (upper left panel). The area was 
stored in the “region of interest” manager. Then the intensity for each channel could 
be measured within each Tim4+ cells (upper right panel). 
 




Statistical analyses were performed using GraphPad Prism 7 software (GraphPad 
Sotware Inc., La Jolla, CA). Differences between two groups or two cell populations 
were determined in two steps : D'Agostino-Pearson omnibus normality test was done 
to rule on the distribution of the data then a nonparametric unpaired Mann-Whitney t 
tests was done (non-gaussian distribution). One way ANOVA on ranks (Krustal-
Wallis H Test) was used to compare two or more groups. Two way ANOVA, with 
multiple comparisons made using Tukey post-hoc tests, was used for analysis of 
variables of two factors (for example sex and diet / treatment and diet), and their 
interaction. Data are shown as mean ± SEM. Full details of analyses are described 






CHAPTER 3 ATM REPLENISHMENT BY BM 
DERIVED MONOCYTES SHOWS TISSUE 
HETEROGENEITY 




WAT is the primary site of lipid storage in the body, and can represent from 5 
to 50% of human body weight. Despite adipocytes being voluminous, immune cells 
constitute the second major component of the tissue, infiltrated between adipocytes. 
AT macrophages (ATMs) have been highlighted during obesity, especially in the 
visceral adipose tissue, as they can expand 10 times in number (Weisberg et al. 2003). 
Most study have then focused on determining the pro-inflammatory phenotype of 
ATMs (Catrysse and van Loo 2018). Nonetheless ATMs represent the most abundant 
immune cells in lean AT, constituting around 5% of the tissue, and their maintenance 
is essential for AT function as ATMs contribute to AT expansion, tissue remodelling, 
lipid buffering, removal of apoptotic adipocytes and non–shivering thermogenesis 
(Ferrante 2013; Thomas and Apovian 2017; Catrysse and van Loo 2018). In lean fat 
depots, F4/80+ ATMs are viewed in the current scientific literature as being anti-
inflammatory M2-macrophages, in contrast with macrophages in obese AT which are 
frequently classified as being inflammatory M1-macrophages (Lumeng et al., 2008). 
These M2 ATMs can express CD206+, CD301+ and encode anti-inflammatory proteins 
(C. N. Lumeng et al. 2008). Despite this M1/M2 classification, ATMs are often 
considered as one group of cells instead of acknowledging their inherent heterogeneity 
of function and/or origin, as seen in other tissues. For instance, the developmental 
origin of ATMs had still not been elucidated and the existence of any local 
maintenance mechanisms had not been investigated which was reflected by the lack 
of ATMs in the biggest reviews on macrophage origin in tissues in the recent years 
(Hoeffel and Ginhoux 2015; Ginhoux and Guilliams 2016). In tissues, resident 
macrophages, which support homeostatic functions, are distinguished from newly 
recruited CCR2+ macrophages which are considered as inflammatory macrophages 
(Davies et al. 2013; Ginhoux and Guilliams 2016). Indeed, inflammation triggers the 
recruitment of Ly6chigh monocytes, which by expressing CCR2, enter the tissues and 
differentiate into ‘recruited’ macrophages (Komornik 1985; Shi and Pamer 2011). 
Conversely, resident macrophages can be embryonically derived, and/or proliferate 
independently from the bone marrow (BM) (Davies and Taylor 2015; Hoeffel and 
Ginhoux 2015; Epelman, Lavine, and Randolph 2014b). To determine the origin of 
tissue macrophages in adults, generation of partial bone marrow (BM) chimeric mice 
Chapter 3 ATM replenishment by BM derived monocytes shows tissue heterogeneity 
 
 44 
is now widely used (Jenkins et al. 2011; Komornik 1985; Calum C Bain et al. 2014). 
By injecting donor BM into a host after partial irradiation, where the tissues of interest 
are shielded, it is possible to follow these cells 8 weeks after reconstitution to evaluate 
the BM dependency of the macrophage population. Injecting Ccr2-/- BM alongside in 
control mice allow to verify the monocytic origin of macrophage in tissues (Calum C 
Bain et al. 2014; Serbina and Pamer 2006; Epelman et al. 2014). One study of this kind 
was done on AT, where authors showed that 85% of ATMs were coming from the BM 
but the researchers used total irradiation which is known now to artificially increase 
the number of cells coming from the BM (Weisberg et al. 2003). Thus, it is important 
to use new technique to investigate ATM BM dependency. In rodent, SAT appears 
before the GAT, and can be studied from birth (Berry et al. 2013). However, SAT 
macrophage composition at birth is not known but could be an indicator of macrophage 
embryonic origin, notably by the study of their F4/80 and MHCII expression (Schulz 
et al. 2012b).  
3.2 Aim of this chapter 
• Determine the origin of ATMs in lean adipose depots of adult mice using 
partial bone marrow chimeras to define resident and recruited macrophages. 
• Follow AT development after birth to study the dynamics of macrophage 
recruitment to the subcutaneous AT (SAT)  
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3.3 Experimental design 
Partial bone marrow chimeras. To study the contribution of monocytes to the 
development of adipose tissue macrophage (ATMs) populations we used adipose 
tissue protected BM chimera in collaboration with the laboratory of Dr Stephen 
Jenkins. Host Ly5.1 female mice (CD45.1+CD45.2+) were partially irradiated (either 
leg irradiation or head irradiation), with a shield covering ¾ of the body and then 
reconstituted with congenic WT BM (CD45.2+) or Ccr2-/- BM. After 8 weeks’ 
recovery, GAT, MES AT and SAT were collected to study the non-host chimerism by 
flow cytometry. 
 
Figure 3.1 Experimental design of partial BM chimera generation  
 
  




3.4.1 Novel gating strategy to characterise adipose tissue 
macrophage subsets  
In AT, macrophages were generally described as being “F4/80+CD11b+” cells. 
However, the gating strategy used by flow cytometry could be refined notably by 
looking at the levels of F4/80 (high or low) and by using Tim4, a phosphatidylserine 
receptor generally used to define resident macrophages in the peritoneal cavity (K. 
Wong et al. 2010). Using F4/80, Tim4 and CD11c, generally used to characterise 
recruited inflammatory ATMs, (Carey N Lumeng, Bodzin, and Saltiel 2007), four 
subsets of ATMs could be distinguished (Figure 3.2A): 
- F4/80+CD11b+Tim4+ CD11c-  (named Tim4+ subset) 
- F4/80+CD11b+Tim4+CD11c+ (named CD11c+ subset) 
- F4/80highCD11b+Tim4-CD11c- (named double negative F4/80high subset) 
-  F4/80lowCD11b+Tim4-CD11c- (named DN F4/80low subset) 
As seen in Figure 3.2B-C, DN F4/80high represented 71% of the ATMs, so the vast 
majority of ATMs. The Tim4+ ATMs were also F4/80high, representing 11% of the 
total ATMs, the CD11c+ were majorly F4/80low (6% of the ATMs), with a negligible 
proportion F4/80high.. To finish the DN F4/80low  only represented 12% of the ATMs.  
  




Figure 3.2 Gating strategy used to define ATM subsets and their relative 
proportion 
A. Density plot showing expression of Tim4 and CD11c (left) on F4/80+CD11b+ 
ATMs and the gating used to define Tim4+ ATMs, CD11c+ ATMs and the expression 
of F4/80 and CD11b on Tim4- CD11c- ATMs (right) and the gating used to define 
Tim4- CD11c- F4/80 high and Tim4- CD11c- F4/80low ATM populations. 
B. Histogram showing Mean Fluorescence Intensity of F4/80 on ATM populations as 
gated in A. 
C. Proportion of each subset within ATM. 
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3.4.2 Tissue non-host chimerism of immune cells in the 
adipose tissue  
The model of protected BM chimeras was used to elucidate the origin of ATMs 
based upon studies released previously in the peritoneal cavity (Jenkins et al. 2011; 
Murphy et al. 2008). In brief, after partial irradiation, Ly5.1 recipient mice (expressing 
CD45.1 and CD45.2) were injected iv with CD45.2 wild type (WT) or Ccr2-/- KO 
donor BM. Chimerism of immune cell populations was studied 8 weeks later in the 
blood. GAT and mesenteric AT (MES AT) were taken to study the replenishment 
(non-host chimerism) of the ATM populations. This was performed by analysing the 
proportion of CD45.2 donor cells for each subset as presented in Figure 3.3. ATMs 
(F4/80+CD11b+) were further divided according to their CD11c and Tim4 expression 
as shown in Figure 3.2.  
  




Figure 3.3 Tissue chimerism of immune cells in GAT 
After irradiation of the legs, Ly5.1 recipient mice (expressing CD45.1and CD45.2) 
were injected iv with CD45.2 wild type (WT) or Ccr2-/- KO donor BM. Non-host 
chimerism was studied by flow-cytometry 8 weeks after irradiation. Dot plot analysis 
showing gating of CD45.1 donor cells in CD45+SiglecF+CD11b+MHCII- eosinophils, 
Ly6c+CD11b+MHCII- monocytes, CD45+Gr1+CD11b+MHCII-  neutrophils and 
CD45+F4/80+CD11b+MHCII+  macrophages (left). Chimerism of ATM subsets were 
further analysed using gating defined in Figure 3.2 (right). 
 
In this model of partial irradiation, granulocytes and monocytes, short lived 
immune cell populations entirely replenished in 8 weeks, showed a non-host 
chimerism of 30%. This percentage was in agreement with the percentage of body 
surface irradiated. As expected, Ly6chi monocytes non-host chimerism was dependent 
on CCR2 as shown by the decrease in non-host chimerism in mice reconstituted with 
Ccr2-/- BM, but the granulocytes were not (Figure 3.4).  
CD45.2 




Figure 3.4 Mice reconstituted with Ccr2 knock-out (Ccr2-/-) BM had a low 
monocyte (Ly6Chi) non-host chimerism but CCR2 deficiency did not affect 
granulocytes.  
Partial BM chimeras were set up as described in Figure 3.3. Graph showing 
non-host chimerism of granulocytes (left) and monocytes (right). Data pooled 
from 3 independent experiments (n=3-5 mice per experiments) and given by 
Calum Bain in Steven Jenkins lab. Bar represents the mean. Student t test ****: 
P<0.0001  
 
In AT, the non-host chimerisms of eosinophils, neutrophils and monocytes 
were similar to the non-host chimerism of granulocytes and monocytes in the blood 
(Figure 3.5). As expected only the Ly6Chigh monocyte compartment non-host 
chimerism was dependent on CCR2 (Figure 3.5). When looking at F4/80+CD11b+ 
ATMs, independently of their Tim4 or CD11c expression, the ATM non-host 
chimerism was lower (14%) compared to the granulocytes and monocytes, but CCR2 
dependent, confirming their monocytic origin. Non-host chimerism in the GAT and 
MES AT were comparable, thus indicating that both tissues had similar degrees of BM 
dependency for these cells (Figure 1.4B).  




Figure 3.5 Non-host chimerism of eosinophils, neutrophils, monocytes and 
macrophages in GAT and MES AT. 
Partial BM chimeras were set up as described in Figure 3.3. Graph showing non-host 
chimerism of eosinophils, neutrophils, Ly6chigh monocytes and ATMs in the GAT (A) 
and MES AT (B). Data pooled from 2 or 3 independent experiments (n=3-5 per group 
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3.4.3 Non-host chimerism of ATM subsets was heterogenous 
ATMs were further divided according to their F4/80, Tim4 and CD11c 
expression, as shown in Figure 3.2. Both DN F4/80low and CD11c+ ATM subsets 
showed a non-host chimerism comparable to blood  monocyte (29%) (Figure 3.6). In 
contrast, the DN F4/80high subset showed an intermediate non-host chimerism (10%) 
and the Tim4+ subset a low non-host chimerism (5%). All non-host chimerisms for 
these ATM subsets were dependent on CCR2 apart from the MES AT where the non-
host chimerism in the Tim4+ population was too low to allow detection of a defect in 
replenishment in Ccr2-/- reconstituted mice.  
To take into account variability in the degree of irradiation that each individual 
mouse was exposed to, the non-host chimerism of each ATM subsets was normalised 
to the WT non-host chimerism of blood monocytes. While CD11c+ and DN F4/80low 
showed a replenishment of up to 100% by host derived cells, dependent on CCR2, and 
the F4/80high subset showed only 40% turnover after 8 weeks which was also dependent 
on CCR2, the Tim4+ ATMs had the slowest turnover  of 10% of cells replaced by 
donor cells after 8 weeks. Once adjusted to blood chimerism, the slow turnover of 
Tim4+ ATMs was not significantly different in mice reconstituted by WT or Ccr2-/- 
BM indicating that replenishment was maybe not dependent on CCR2 expression by 
monocytes or only very slowly replenished by the BM and could not be detected after 
8 weeks (Figure 3.7). F4/80low ATMs (CD11c+ of or not) were significantly more BM 
dependent than F4/80high ATMs. The “waterfall” transition from monocytes to 
macrophages (F4/80 and MHCII acquisition and loss of Ly6c ) can be observed in this 
gate and is the illustration of their BM dependency (data not shown).  
  




Figure 3.6 ATM subsets in GAT and MES AT showed an heterogeneous non-host 
chimerism 
Partial BM chimeras were set up as described in Figure 3.3. Data reprensent the non-
host chimerism for each ATM subsets, described in Figure 3.2. Data pooled from 2 
independent experiments (n=3-5 per group per experiment). Bar represents the mean. 
 Student t test ****: p<0.0001; *** p<0.001  
  




Figure 3.7 Tim4+ ATMs had the lowest normalised non-host chimerism which 
could not be distinguised from the mice injected with CCR2 KO when 
compared to other ATM subsets. 
Partial BM chimeras were set up as described in Figure 3.3. Non-host chimerism of 
each ATM subsets, gated in Figure 3.2, was normalised by the non-host chimerism 
of blood monocytes of the WT mice. Data pooled from 3 independent experiments 
(n=3-5 per group per experiment). Column shows the mean for each group. One-
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3.4.4 Head irradiation as a method to study macrophage 
replenishment in tissues located in the peritoneal cavity 
The difference between MES AT and GAT non host chimerism in the resident 
Tim4+ subset suggested that irradiation of the back legs may have partially exposed 
the GAT to irradiation, as this depot is located lower than the MES AT. By doing so, 
it is possible that it displaced the Tim4 ATMs and increased the non-host chimerism 
artificially. In collaboration with the laboratory of Dr Stephen Jenkins, head 
irradiations were conducted to verify this hypothesis (Figure 3.8). After normalisation 
to the chimerism of the blood monocytes for each mouse, the leg irradiation led to a 
low non-host chimerism for the Tim4+ subset as found previously. However by 
irradiating the head, the percentage of chimerism in the Tim4+ subset in the GAT was 
not different from the MES AT (Figure 3.8). Furthermore, during this experiment, the 
subcutaneous ATMs population was also studied. The Tim4+ ATM subset in the 
subcutaneous AT (SAT) had a similarly low non-host chimerism compared to the MES 
and GAT. Thus head irradiation is a safer option to study ATM replenishment.  
 
Figure 3.8 Head irradiation decreased differences of Tim4+ non-host chimerism 
between the GAT and the MES AT, and was a better option to study ATM 
replenishment using partial BM chimera 
Partial BM chimeras were set up as described in Figure 3.3, except that some mice 
were head irradiated, while some mice were leg irradiated. The non-host chimerism of 
Tim4+ ATMs, as gated in Figure 3.2, was normalised by the non-host chimerism of 
blood monocytes for each mouse. Tim4+ macrophages from GAT, MES AT and 
Subcutaneous AT (SAT) were analysed. Data from 1 experiment (n=5). Student t test 
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3.4.5 Phenotyping of ATMs in lean GAT   
Having established the existence of at least 4 subsets of ATMs with various 
degrees of dependency on BM monocyte for their replenishment, these subsets were 
further characterised by using other macrophage markers used broadly in the literature 
(Figure 3.9). All subsets expressed CD115 or colony stimulating factor-1 receptor 
(Csf1R), which is expressed by all macrophages in tissues and control their 
development and differentiation (Jenkins and Hume 2014). Interestingly all ATMs 
expressed Relma (resistin-like molecule alpha), a marker associated with repair. 
F4/80high macrophages (Tim4+ and Tim4-) expressed CD206 and CD301 (data not 
shown), markers associated with endocytosis, phagocytosis, repair and alternative 
activation (Haase et al. 2014b). CD64, a Fc-gamma receptor, is used to differentiate 
ATMs from dendritic cells (DCs) in AT (Cho et al. 2016). F4/80high ATMs expressed 
CD64 in greater proportion than F4/80low ATMs, indicating than the latest could be 
freshly differentiating from monocytes in the tissue.  
 
Figure 3.9 Histograms showing CD64, CD206, Csf1R and Relmα expression on 
ATMs macrophages  
ATMs from GAT were stained for  CD64, CD206, CD115 and Relma. The negative 
control (fluorescence minus one) is represented in plain grey for each subset. 
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3.4.6 Tim4+ ATMs were resident in subcutaneous AT and 
present at birth at a very low proportion  
SAT macrophage description is still limited and, as for the visceral AT, their 
origin is not known. SAT is present at birth, contrary to the GAT (Wang et al. 2013). 
Therefore combining both chimeras (in adults) and time course in new born could be 
a simple method to follow macrophages dynamic during development, when other 
methods are not available. It was not always possible to distinguish a clear F4/80high 
and F4/80low population in adult SAT. This was possibly due to the lower number of 
ATMs recovered from the SAT compared to GAT and MES AT. Therefore ATMs in 
the SAT were divided in 3 subsets, disregarding their F4/80 expression, as shown in 
Figure 3.10 : Tim4+, CD11c+ and Tim4-CD11c- (double negative: DN). After head 
irradiation, the three subsets of ATMs showed the same pattern of non-host chimerism 
as ATMs in the GAT. CD11c+ cells showed a high non-host chimerism comparable to 
blood monocyte and Tim4+ cells showed a low non-host chimerism.  
 
 
Figure 3.10 SAT macrophages were heterogeneous and Tim4+ ATMs had a low 
BM dependency.  
After head radiation, wild type CD45.1 bone marrow was injected intraveneously to 
CD45.1/.2 mice, and followed after 8 weeks of replenishment. The non-host 
chimerism is the percentage of CD45.1 cells within each subsets. 
A. Cells were gated on live CD45+SiglecF-Ly6c-MHCII+F4/80+CD11b+ and divided 
on their Tim4 and CD11c expression. (B). Tissue non-host chimerism. Data from 1 
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To study the origin of the resident Tim4+ ATMs, SAT was taken from pups 
and analysed by flow cytometry over a time course from birth to adulthood. Typically, 
yolk sac derived macrophages present a F4/80bright phenotype, contrary to F4/80low 
cells, derived from HSC, thus this could be an indicator of ATM origin (Schulz et al. 
2012b). At birth, SAT was void of lipids (data not shown) and weighing aroung 5 mg 
(Figure 3.11). Quickly, the size of the fat pads expanded (ten-fold heavier after 1 week) 
and reached around 230 mg at 4 weeks and remained stable up to adulthood. At birth 
all macrophages were F4/80high , suggesting a YS origin. Shortly after, during SAT 
expansion, a F4/80low population was distinguished up until 4 weeks, then the frontier 
between the F4/80low and F4/80high ATMs was less clear (Figure 3.12A). Moreover, as 
shown in Figure 3.12B, shortly after birth (postnatal day 1: P1) the F4/80high 
macrophages present were MHC-IIlow (population IV), again resembling what have 
been described in the literature as being YS derived macrophages (Ginhoux and 
Guilliams 2016). At the first week of life (P7), MHC-IIhigh cells appeared (population 
I) and this pool kept growing to finally become the majority of adult SAT macrophages 
(population I and II). The resident Tim4+ ATMs appeared between P1 and P7 
(population III) and they acquired MHC-II (population II) after weaning (P21). In 
terms of relative proportion, Tim4+ ATMs in the SAT reached a peak around weaning 
(P21) and then their proportion remained stable (pop II + III), with a mix of MHC-
IIhigh and MHC-IIlow cells (Figure 3.12C). There might be a mix origin of macrophage 
in the SAT, with YS derived cells at first and then participation of BM derived cells 
(F4/80low) that acquired MHCII. However without lineage tracing it would be difficult 
to confirm these findings.  
 




Figure 3.11 Evolution of SAT weight during mouse development 
SAT was taken from mice and weighed to follow fat mass evolution from P1 
(post-natal day 1) to adulthood (8w = 8 weeks). Data representative of 2 independent 
experiment (n=4). 
Figure 3.12 SAT contains yolk sac derived F4/80highMHCIIlow  macrophages at 
birth 
A Density plot showing SAT ATMs (CD45+F4/80+CD11b+ cells; circled) during a 
time course: P1 (post-natal day 1), P7 (post-natal day 7), P21 (post-natal day 21), and 
at 4 weeks and 8 weeks after birth B. Density plot showing the evolution of MHCII 
and Tim4 expression in the F4/80high macrophage population during SAT 
development. C. Relative proportion of each subsets represented in B. Data 
representative of 2 independent experiment (n=3-4). 
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The main results of this chapter are summarised in the Table 3-1. 
Table 3-1 Summary of findings from chapter 3 





monocyte after 8 
weeks 
Proportion 
in the tissue  
Tim4+ low Low Very slow  11% of ATMs 
CD11c+ Yes High Quick  6% of ATMs 
F4/80high Yes Intermediate Slow 71% of ATMs 
F4/80low Yes High Quick  12% of ATMs 
 
Importance of partial body irradiation and gating strategy to study ATMs 
In previous studies, partial body irradiation (legs irradiation) used to study 
macrophages in the peritoneal cavity, showed the same blood non-host chimerism to 
the one in the set of experiment realised for this chapter (of about 30%) (Jenkins et al. 
2011). This reflects a good reproducibility of the technique. However, unintentional 
irradiation of some tissue can lead to an artificial increase in non-host chimerism. This 
can be explained by the niche competition between recruited and resident macrophages 
(Guilliams and Scott 2017). Indeed, irradiating the tissue can deplete resident ATMs 
thus, the “niche” being free, these macrophages could be replaced by recruited 
monocytes in order to restore their number (Guilliams and Scott 2017). However, 
resident macrophages can repopulate a tissue by proliferation, in a M-CSF dependent 
manner (Hashimoto et al. 2013). Head irradiation seemed to be a good alternative to 
the irradiation of the legs, so the tissues are untouched and studies of residency can be 
performed.  
By only defining ATMs as being F4/80+CD11b+ cells, the non-host chimerism 
8 weeks post-legs irradiation was of 12% in GAT and MES (around 41% once 
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normalised). It was only by dividing F4/80+CD11b+ ATMs into subsets that the 
diversity in BM dependency appeared which emphasis the need of characterising 
better ATMs to understand their origin. Recently, an another group used partial BM 
chimera with head irradiation to study ATMs in the GAT, and found a ATM non-host 
chimerism of 3.57% 15 weeks post-irradiation, then 14% 19 weeks post irradiation 
(Zheng et al. 2016a). In their study, ATMs were defined as Siglec-F-F4/80+ cells. 
Differences between their groups (3.57% vs 14% in only few weeks apart), but also 
with results presented in this chapter could be due to two things: first, their gating 
strategy based on Siglec-F-F4/80+ seemed limited. Secondly, the consistency of the 
operators to performed irradiation could be questioned. As shown by the legs versus 
head irradiation, how irradiations are performed can artificially increase non-host 
chimerism. Normalisation by blood chimerism could potentially decrease differences 
between independent experiments, assuming that tissues of interest are not irradiated.  
Macrophages were recruited at homeostasis in lean AT 
The current dogma is that ATMs recruitment occurs mainly during obesity 
(Weisberg et al. 2003; Reilly and Saltiel 2014; Patsouris et al. 2008a). However, our 
results suggested that, in lean AT, at least 18% of ATMs (CD11c+ and DN F4/80low) 
were highly dependent on the BM and 71% (DN F4/80high ) were partially dependent. 
If only looking at the literature, recruited ATMs are characterised as M1 macrophages, 
pro-inflammatory, thus their presence in lean healthy tissue could be a paradox (C. N. 
Lumeng et al. 2007). The M1/M2 classification has to be challenged as, even though 
it could work in vitro after supervised stimulations with LPS or IL4, the in vivo reality 
is different. These recruited M1 macrophages did express what the literature classifies 
as M2 markers (Martinez and Gordon 2014). Indeed, by adding more markers to the 
panel, it was to notice that macrophages with higher chimerism, also expressed Relm-
α, a M2 marker according to the literature (Zheng et al. 2016b). Actually, Relm-α was 
uniformly expressed by the CD11c+ subset, while this marker showed some 
heterogeneity in expression in the resident subset. In the murine serous cavity, Relm-
α defines macrophages with a high non-host chimerism, CCR2 dependent, thus 
monocyte derived (Calum C Bain et al. 2016). Interestingly, the authors suggest that 
the fraction of F4/80high macrophages expressing Relm-α derive from F4/80low 
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macrophages. This could indicate that Relm-α could also delimit other subtypes of 
ATMs within the DN F4/80high and Tim4 subsets with different BM dependency. More 
markers would be needed to dissociate them or, ideally, techniques such as single cell 
RNA sequencing.  
Tim4+ were resident macrophages which may not require CCR2 to enter 
the tissue in adults GAT and MES AT 
Tim4+ is a PS receptor that recognise apoptotic cells, which typically express 
PS at their surface as a “eat me” signal to be recognised and engulfed by macrophages 
(Miyanishi et al. 2007; Nishi et al. 2014). Tim4 is expressed on resident peritoneal 
macrophages, spleen macrophages, gut macrophages and Kupffer cells (Davies et al. 
2013; Shaw et al. 2018). Eight weeks post irradiation, Tim4+ ATMs showed  a very 
low non-host chimerism. If compared with mice injected with CCR2 KO BM, the 
difference in normalised chimerism between WT and CCR2 KO donor groups was 
non-significant, which could mean that CCR2 is dispensable for their entry to the 
tissue. CCR2 is the receptor for monocyte chemoattractant protein 1(MCP1 / also 
known as CCL2) produced by tissues. CCR2  is usually expressed by monocytes and 
recruited macrophages (C. N. Lumeng et al. 2007). In Ccr2-/-  mice, fewer monocytes 
are present in the bloodstream, as they fail to exit the BM and be recruited to tissues 
upon MCP-1 release (Tsou et al. 2007). However, Ccr2-/-   mice still contain ATMs (C. 
N. Lumeng et al. 2007). Either the remaining ATMs rely on other recruitment signals 
to enter the tissue or, resident macrophages are evolving independently from the BM, 
by proliferation. For example, in the small intestine, Tim4+ macrophages were 
dominant in Ccr2-/-  mice (Shaw et al. 2018). They were present at birth in high 
proportion, and the authors hypothesised these to be FL derived or from an early BM 
influx of monocytes. These cells were also found to be maintained independently from 
the BM (Shaw et al. 2018). Similarly, Kupffer cells are also maintained independently 
from the BM, however, monocytes contribute to their pool during liver development 
as well as embryonically derived macrophages (Scott et al. 2016). Looking at these 
data together, Tim4+ ATMs could potentially be a self-replenishing population that 
might find their origins in early monocyte recruitment to the GAT.  
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Tim4+ ATMs could be yolk sac derived in the SAT at birth 
Macrophage origins have been thoroughly described in the literature, with the 
exception of ATMs. GAT is absent in the murine embryo, however the subcutaneous 
AT develops in utero (Wang et al. 2013) which allowed the study of possible 
embryonic macrophages seeding this tissue and persisting with age. SAT was 
populated by F4/80high macrophages at P1, which were mainly Tim4-MHCIIlow. 
F4/80high (also called “bright”) macrophages are characteristic of yolk sac (YS) derived 
macrophages in tissues thus indicating that macrophages present at birth in the SAT 
might also be of YS origin (Schulz et al. 2012b; Hoeffel et al. 2012). F4/80low 
macrophages entered the tissue around P7, certainly coming from the BM. These 
macrophages could be monocyte derived and indicate that SAT has a mix population 
of macrophages during the first week(s) of life. 
A small proportion of Tim4 ATMs was present at birth and grew in number 
during SAT development. Either these Tim4+ ATMs are recruited from the BM or 
derived from the F4/80high macrophages present at birth. In the heart, MHC-IIhigh 
macrophages are derived from embryonic MHC-IIlow macrophages (Epelman et al. 
2014), which indicated that embryonic macrophages can acquire more markers with 
time which could also be the case for the Tim4+ SAT macrophages. F4/80high YS 
macrophages might acquire Tim4+  and MHCII over time and persist in the tissue by 
self-renewal which would explain the low chimerism in adult. Nonetheless, 
F4/80lowMHC-IIhigh ATMs could replace the YS derived cell over time, acquire Tim4 
and proliferate in the tissue. For example, in the peritoneal cavity, newly recruited cells 
from the BM acquire in fine the same phenotype as the previous F4/80bright embryonic 
macrophages but first they undergo a F4/80lowMHCII+ stage (Calum C Bain et al. 
2016). Lineage tracing such as injection of tamoxifen at E.8 in Csf1r-mer-iCre-mer 
crossed with Rosa26-LSL-YFP reporter mice pregnant female would label embryos 
YS derived macrophages with YFP and the follow up of these cells by flow cytometry 
could give more definite informations about macrophage origin in the SAT (Schulz et 
al. 2012b). Interestingly Tim4+ ATM population seem to expand at a time where lipids 
started to fill adipocytes in the SAT (around P4) certainly inducing an important tissue 
remodelling and cell death which require Tim4+ ATMs to clear the tissue.  




We identified 4 populations of ATMs in adipose tissue showing different degree of 
dependency on the BM for their maintenance in adult GAT and SAT. In the next 
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  Obesity has become a worldwide epidemic affecting around 650 million 
individuals (“WHO | Obesity and Overweight” 2018). Obesity causes a low grade 
inflammation, related to the excessive AT expansion (Ye 2013). Visceral AT 
accumulation is associated with an increased risk of developing insulin resistance and 
type 2 diabetes. In contrast, accumulation of AT below the waist, in the subcutaneous 
AT, appears to be less detrimental (Pereira and Alvarez-Leite 2014; Fu, Hofker, and 
Wijmenga 2015). Interestingly females accumulate less VAT than males during HFD, 
which is also associated with less macrophage infiltration and less inflammation  
(Fuente-Martín et al. 2013). The link between AT inflammation during obesity and 
macrophages recruitment was established in the early 2000s. Weisberg et al. revealed 
that macrophage numbers were multiplied by 5 in obese mice and were linked with 
pro-inflammatory cytokine release (Carey N Lumeng, Bodzin, and Saltiel 2007). By 
creating chimeras with full body irradiation, they showed that most ATMs were 
recruited from the BM during obesity (Weisberg et al. 2003). However a later study 
showed that after 7 weeks of HFD, local macrophage proliferation occurred and 
contributed to ATM number increase (Amano et al. 2014). These two conflicting 
results show the necessity to further study ATMs to understand their origins in the 
tissue. Moreover, these studies mainly considered macrophages as a whole instead of 
defining functional subsets, with the novel exception of CD11c expressing 
macrophages (Patsouris et al. 2008a; Li et al. 2010; Carey N Lumeng, Bodzin, and 
Saltiel 2007). Indeed CD11c+ ATMs have been linked with insulin resistance, AT 
inflammation and whole body low-grade inflammation during obesity (Patsouris et al. 
2008b; Carey N Lumeng, Bodzin, and Saltiel 2007; J. M. Wentworth et al. 2010). The 
discovery of a novel resident Tim4+ macrophage population that was discussed in 
chapter 3, plus the fact that ATM recruitment is very heterogeneous, raises the question 
of how each subset would change during HFD feeding. As females and males do not 
seem to have the same AT expansion and macrophage recruitment dynamic, sex 
differences in ATM phenotype will also be considered. 




In the previous chapter, four ATM subsets were found in the GAT, including 
a Tim4+ population with a very low BM dependency, DN F4/80high subset with an 
intermediate BM dependency and two subsets (CD11c+ and DN F4/80low) with a high 
BM dependency. In the SAT, due to lower cell number, it was more difficult to find a 
clear distinction between DN F4/80high and DN F4/80low so these subsets were 
considered as one population defined as DN.  
The aims of this chapter are: 
- To follow the changes in ATM recruitment after 8 weeks of HFD using 
partial BM chimeras (head irradiation), in SAT and GAT. 
- To compare macrophage recruitment dynamics within male and female 
adipose depots during HFD feeding.  
- To investigate the impact of HFD on the novel resident Tim4+ ATM 
population 
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4.3 Experimental design  
Partial BM chimeras coupled with HFD. To study the contribution of monocytes to 
the development of ATM populations we used adipose tissue protected BM chimera 
in collaboration with the laboratory of Dr Stephen Jenkins. Host mice (males and 
females) (CD45.1+CD45.2+) were partially irradiated (head irradiation), with a shield 
covering ¾ of the body and then reconstituted with congenic WT BM (CD45.2+). After 
4 weeks of recovery, a control diet (CD) or a HFD (HFD; 60% fat) was provided ad 
libitum for 8 weeks. GAT and SAT were collected to study the non-host chimerism by 
flow cytometry.   
  
Figure 4.1 Experimental design of partial BM chimeras coupled with diet to study 
macrophage turn-over during HFD. 
After irradiation of the head, Ly5.1 host mice (expressing CD45.1 and CD45.2), both 
males and females, were injected i.v. with CD45.2+ donor BM. After recovery, mice 
were then put on a control diet or a HFD (60% fat) for 8 weeks. Non-host chimerism 
was studied at the cull in the blood, GAT and SAT.  
  




4.4.1 Heterogeneity in weight gain and macrophage number 
between adipose depots  
Males accumulated similar amount of GAT than females when compared 
to body weight  
After generation of BM chimeras (as shown in Figure 2.2), and 8 weeks of 
either a control diet or HFD, mice (males and females) were sacrificed. As anticipated, 
after 8 weeks of HFD, both males and females put on weight significantly compared 
to the control groups (Figure 4.2A). Both the subcutaneous and gonadal adipose depots 
were heavier in mice fed on a HFD compared to the control mice in both male and 
female mice (Figure 4.2). Nonetheless, female adipose depots were smaller when 
compared with their male counterparts (Figure 4.2 A). However, if normalised by body 
weight (BW), there was no more sex differences (Figure 4.2 B). Therefore, the GAT 
expansion was proportional to the weight gain in males and females, even if males 
contained more GAT than females. 




Figure 4.2 Males accumulated more GAT and SAT than females after 8 weeks 
of HFD but when compared to body weight, the differences were null.   
Partial BM chimeras were set up as described in Figure 2.2. A. Weights of mice 
before and after 8 weeks of HFD C.  GAT (left) and the SAT (right) were weighed 
(grams) after 8 weeks of control diet or HFD. C. GAT and SAT weights reported to 
the body weights (BW).Data pooled from 2 independent experiments (n=4-6 per 
group per experiment). The bar represent the SEM. Two-way Anova was performed 
to determine the p-value. ****: p<0.0001; **: p<0.01 
 
Males had more macrophages in the GAT than females 
The total number of GAT macrophages (F4/80+CD11b+ cells) showed a nearly 
3 fold increase in the male mice. In female mice, GAT ATM number only increased 
slightly (Figure 4.3, left). In the SAT, the total number of ATMs remained constant 
for both sexes and diets (Figure 4.3, right). 




Figure 4.3 The total number of macrophages in the GAT increased in male but 
not in female mice nor the SAT after 8 weeks of HFD. 
Partial BM chimeras were set up as described in Figure 2.2. The total number of ATMs 
per fat pad was assessed in the GAT (left) and the SAT (right) using live cell count of 
the stromal vascular fraction and flow cytometry.  
Data pooled from 2 independent experiments (n=4-6 per group per experiment) for 
SAT and male GAT, 1 experiment for female GAT (n=5). Two-way Anova was 
performed to determine the p-value. ****: p<0.0001 
 
4.4.2 Heterogeneity of recruitment during HFD is sex and 
depot specific  
First, male and female ATM turnover were compared by analysis of the non-host 
chimerism. In the GAT, there was no significant differences in non-host chimerism 
between males and females independently of the diet for the CD11c+ and DN F4/80low 
subsets (Figure 4.4). However changes occurred within the subsets with lower 
chimerism. The DN F4/80high and Tim4+ macrophages had a higher chimerism in lean 
male compared to lean female. With HFD, DN F4/80high non host chimerism increased 
in males, but not in females, implying a higher turnover of these cells during obesity 
in males but not females. Even though the chimerism of Tim4+ macrophages did not 
increase with HFD in both sex, male Tim4+ macrophages had a higher non-chimerism 
after HFD compared to the females fed with the same diet. This suggested than Tim4+ 
macrophages in females were more slowly replaced. 
In the SAT (Figure 4.4B), the DN subset non-host chimerism increased in 
obese males and was significantly higher than in the obese females. Although the 
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significant), the obese females showed a significant increase in chimerism. Implying 
that the Tim4+  population in the SAT relied more on the BM for its replenishment.  
 
Figure 4.4 DN F4/80high and Tim4+ non-host chimerism showed the highest sex 
specificity, in the GAT (A) and SAT (B), after 8 weeks of HFD (red)  
Partial BM chimeras were set up as described in Figure 2.2. The percentage of 
chimerism was normalised by the Ly6chigh chimerism in the blood for each mouse. 
Data pooled from 2 independent experiments (n=4-6 per group per experiment) for 
SAT and male GAT, 1 experiment for female GAT (n=5). In black : control diet; in 
red : HFD. Bars represent mean v. Two-way Anova was performed to determine the 
p-value **** : p<0.0001; **: p<0.01; *: p<0.05 
 
4.4.3 Heterogeneity of ATM recruitment during HFD 
Non-host chimerism of Tim4+ ATMs did not increase with HFD 
To better compare the impact of HFD on non-host chimerism, male mice were 
utilised as they gained more weight and had the most striking increase in macrophage 
number. Their non-host chimerism was normalised by the Ly6chigh monocyte non-host 
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HFD group. When considering ATMs (F4/80+CD11b+ cells) as one population, the 
normalised chimerism was 39.5% (± 6.3)  in mice fed a control diet, and 71.5% (± 9.5) 
in mice fed a HFD (Figure 4.5).  
 
Figure 4.5 ATM non-host chimerism was increased during HFD in the GAT of 
male mice. 
Partial BM chimeras were set up as described in Figure 2.2. Non-host chimerism was 
measured as showed on the FACS plot, by gating on CD45.2 cells within the 
F4/80+CD11b+ gate (after exclusion of eosinophils, neutrophils, monocytes). The 
percentage of chimerism was normalised by the Ly6chigh chimerism in the blood for 
each mouse and is represented in the between bracket as mean ± SEM . Representative 
data from 1 of 2 independent experiments (n=4-5 per group per experiment). 
 
As seen in chapter 3, it was only when the ATM population was considered as 
defined subsets delineated using surface expression of CD11c, CD11b, F4/80  and 
Tim4 that the heterogeneous ATM recruitment dynamics could be unveiled. The DN 
F4/80high subset had the highest non-host chimerism increase due to HFD. Although 
CD11c+ and DN F4/80low ATMs also increased due to input from the donor BM., the 
changes were not statistically significant. However, both subsets were already nearing 
maximum turnover of 100% in the lean state. As for the Tim4+ ATMs, they conserved 
their low BM chimerism, irrespective of the diet that the mice were fed (Figure 4.6A). 
The number of recruited macrophages increased in the GAT during HFD 
The number of cells within each subset raised during HFD : F4/80low had a 13.6 
fold increase, CD11c+  a 12.9 fold increase, DN F4/80high a 6.4 fold increase and Tim4+ 
a 5 fold increase. For each subset, when comparing the total number of ATMs in the 
tissue with the number of cells coming from the BM, Tim4+ macrophages showed the 
lowest number of cells coming from the BM. While the Tim4+ macrophage numbers 
in the tissue increased, the input of BM derived cells was very minimal, suggesting 
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that this population was increasing via proliferation expansion (Figure 4.6B), which 
was confirmed by a later experiment. In contrast, the total number of CD11c+ cells in 
the AT was equivalent to the number of CD11c coming from the BM indicating that 
this population was entirely dependent on BM derived cells for its increase during 
HFD. ATM recruitment during HFD seemed to outnumber Tim4+ ATMs, as their 
relative proportion went from 24% in lean mice to only 16% of ATMs in obese mice 
(Figure 4.6C). CD11c+ macrophages, who were linked with inflammation in previous 
studies, had an increase of 64% (from representing 14% in control mice to 23% in 
obese mice). This increase was the highest increase in proportion in the tissue.  
 




Figure 4.6 Tim4+ ATMs did not rely on the BM to increase in number during 
HFD but their overall proportion decreases due to the arrival of BM derived 
ATMs in the GAT after 8 weeks of HFD (males). 
Partial BM chimeras were set up as described in Figure 2.2. Non-host chimerism 
was assessed in GAT from male mice (A) after a control diet (black dots) or HFD 
(red dots) (data pooled from 2 independent experiments, n= 4-6 per group per 
experiment ; student t test ** p<0.001) B. The number of macrophages for each 
subset in the tissue compared to the number of cells coming from the BM in mice 
fed a CD or a HFD C. Proportion of each subset in lean or obese mice (Data 
representative of 1 from 2 independent experiments).  
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Tim4+ macrophages proliferated during HFD 
To measure proliferation, macrophages were stained with Ki67, a protein absent 
from quiescent cells, and the percentage of Ki67 positive ATMs was measure by 
flow cytometry. As expected, Tim4+ ATMs had a higher proliferation level during 
HFD (14%) and although not significant, higher than the other ATM populations 
confirming that their maintenance was dependent on self - renewal by proliferation 
than by input from the BM during HFD.  
Figure 4.7 Tim4 macrophages proliferated in the GAT during HFD, as measured 
by Ki67. 
Mice were fed a HFD for 14 weeks (red) or a control diet (black). ATMs were stained 
using Ki67, a marker of proliferation, and analysed by flow cytometry. The percentage 
of Ki67+ cells for each subsets is represented in the histogram. Data pooled from 2 
independent experiments. Bar represent the mean ± SEM. Student t test *** p<0.0001. 
 
4.4.4 ATMs had dynamic changes in MHCII expression and 
lipid content during the course of HFD  
ATMs have previously been described as becoming lipid-laden during HFD 
feeding, notably the CD11c+ ATMs (Grijalva et al. 2016; X. Xu et al. 2013). To study 
the impact of HFD on ATM lipid content, mice were put on a HFD for 8 weeks, and 
after ATM isolation from the GAT, cells were analysed by flow cytometry.  
After 8 weeks of HFD, new subsets of macrophage with a lower expression of 
MHC class II appeared in the tissue. The analysis of MHCII surface expression (gMFI 
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MHCIIlow in obese mice (Figure 4.8). The non-host BM chimerism of these subsets 
was unchanged compared to the MHCIIhigh cells within the same subset (data not 
shown). 
 
Figure 4.8 Tim4+ ATM MHCII expression decreased after 8 weeks of HFD 
After 8 weeks of HFD, GAT macrophages were analysed after staining by flow 
cytometry. A. FACS plot of MHCII expression on Tim4 macrophages in lean and 
obese mice and (B) geometric mean fluorescence intensity and histograms of MHCII 
expression on ATM subsets during control diet (black) or HFD (red). Student’s t test : 
*:p<0.05; **p<0.01  
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Macrophage granularity was also assessed by looking at the side scatter area 
(SSC-A), a higher SSC-A correlating with a higher granularity or internal complexity. 
ATMs (F4/80+CD11b+) from obese GAT had a higher percentage of cells with an SSC-
Ahigh phenotype, notably within the CD11c+ and Tim4+ subset (Figure 4.9A-B). The 
analysis of the geometric mean fluorescence intensity (gMFI), a measure of per-cell 
fluorescence levels, of Lipidtox, a dye for neutral lipid content, showed that the higher 
the SSC-A, the higher the neutral lipid content of these macrophages was (Figure 
4.9C). Moreover, analysis of lipid content within each ATM subset, as opposed to the 
whole population, showed that in lean and obese AT, Tim4+ macrophages, tended to 
contain more lipids than the 3 other subsets, in both lean and obese mice (Figure 4.10).  
 
Figure 4.9 SSC-Ahigh macrophages are more abundant during HFD and contain 
more neutral lipids  
After 8 weeks of HFD, ATMs from GAT were analysed by flow cytometry to measure 
their lipid content after LipidTox staining. SSC-Ahigh ATMs (F4/80+CD11b+) were 
distinguished from SSC-Alow (A) and were quantified (B) as a percentage of SSC-Ahigh 
cell within the subset. C. ATM lipid content analysed using LipidTox staining by flow 
cytometry (geometric mean fluorescence intensity: gMFI). In black: ATMs from 
control diet mice; in red: macrophages from HFD mice. Data representative of 2 























































































Figure 4.10 Tim4+ ATMs from lean and obese mice tended to have the highest 
lipid content.  
After 8 weeks of HFD or control diet, ATMs from GAT were analysed by flow 
cytometry to measure their lipid content after LipidTox staining. The gMFI 
(geometric mean of intensity) was used to compare the 4 different ATM subsets 
(n=3 to 4 mice per diet). Data representative of 1 from 2 independent experiments. 
After 14 weeks of HFD, all ATMs significantly increased their proportion of lipid 
filled SSC-Ahigh cells (Figure 4.11A). CD11c+ macrophages had the highest proportion 
of SSC-Ahigh cells, followed by the Tim4+ macrophages. By sub-dividing subsets 
according to their MHCII expression (high and low), it was interesting to see that 
Tim4+ SSC-Ahigh macrophages were mainly MHCIIlow meanwhile the CD11c+ SSC-
Ahigh were MHCIIhigh (Figure 4.11B and C). As a whole, the Tim4+ MHCIIlow 
macrophages had a higher SSC-A than their counterpart MHCIIhigh  (data not shown) 
cells, indicating that this subset would be a good lipid scavenger without increasing 
antigen presentation. 




Figure 4.11 SSC-A and MHC-II expression on adipose tissue macrophages    
After 14 weeks of control diet or HFD, ATMs were analysed by flow cytometry.  
A. Quantification of the percentage of SSC-Ahigh ATMs within each population.  
B. MHC-II expression and SSC-A allowed the subdivision of ATMs Tim4+ and 
CD11c+ (C) of lean mice and obese mice. 
 Q1: MHCIIlowSSChigh Q2 MHCIIhigh SSChigh Q3: MHCIIhigh SSClow Q4: MHCIIlow 
SSClow . The graph shows the percentage that represent Q1-Q4 within the subset.  
Representative of 2-3 independent experiments of n=4 to 6 mice per group per 
experiment. Student t test :  *p<0.05 ***p<0.001;****p<0.0001  
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4.4.5 Tim4+ ATMs were filled with lipids and lysosomes at 
homeostasis and during obesity 
As shown previously (Figure 4.10), Tim4+ macrophages were filled with lipid 
during HFD, but also on control diet. Morphologically, after fluorescence activated 
cell sorting and H&E staining, they appeared to contain vesicles, reflecting their higher 
internal complexity. Utilising whole mount staining of GAT,  the internal vesicles of 
Tim4+ ATMs were confirmed to contain lipids (lipidtox staining), these droplets could 
be distinguished within ATMs, in both lean (Figure 4.12B) and obese mice (Figure 
4.12C), supporting the data acquired by flow cytometry and presented in Figure 4.9 
and Figure 4.10. 
  




Figure 4.12 Tim4+ ATM morphology in lean and obese GAT 
A. H&E staining after FACS sort of Tim4+ macrophages from digested GAT (scale 
bar: 5µm) 
B. Whole mount staining (objective x40) of lean GAT and obese adipose tissue (C), 
showing neutral lipids (Lipidtox (green)), CD11b (magenta) and Tim4 (grey). Scale 
bar: 20 µm 
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 The high granularity could also be explained by the presence of lysosomes 
within the cells. Tim4+ ATMs contained numerous active lysosomes, as shown by 
lysotracker staining (Figure 4.12B). To confirm these results, ATMs were also stained 
with Lamp1, a protein found at the lysosome’s surface and commonly used for flow 
cytometry. Analysis showed that similarly to lysotracker, Tim4+ ATMs contained 
more Lamp1 fluorescence (Figure 4.13). Due to the absence of CD11c staining during 
the experiment, ATMs were divided in F4/80high and F4/80low. Most of the CD11c+ 
macrophages are F4/80low as seen previously in chapter 3. F4/80low macrophages had 
the lowest Lamp1 gMFI, the F4/80highTim4- ATMs had an intermediate Lamp 1 
content (Figure 4.13). There was no difference in Lamp 1 gMFI between the lean and 
obese GAT.  
 
Figure 4.13 Tim4 ATMs tended to have more lysosomes, as shown by Lamp1 
expression, compared to other macrophage populations in lean and obese GAT  
Male mice were put on HFD or control diet for 14 weeks. Cells were stained and 
analysed by flow cytometry. Lysosomal-associated membrane protein 1 (Lamp1) 
geometric mean fluorescence intensity (gMFI) was used to measure lysosomal content 
within F4/80high, F4/80low and Tim4+ macrophages. Data representative of 2 
independent experiments  
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4.4.6 Tim4+ ATMs were better at LDL uptake  
 As Tim4 ATMs contained more lipids and more lysosomes, their capacity to 
uptake lipids was tested in comparison to other ATMs. LDL, a low density lipoprotein, 
was added to wells containing ATMs. LDL was coupled with a fluorescent dye, 
BODIPY, so it was possible to quantify its uptake by macrophages using flow 
cytometry. It is known that CD36 is a class B scavenger receptor, expressed by 
macrophages and involved in lipid uptake (Kunjathoor et al. 2002; Aouadi et al. 2014).  
In lean AT, CD36 had a similar expression on all the macrophage subsets (data not 
shown). CD36 expression was also analysed after LDL addition. After 2 hours, Tim4+ 
ATMs contained more LDL than other ATMs, and this difference increased over time. 
CD36 expression peaked at 4h but surprisingly was decreased at 6h post LDL feeding. 
CD36 tended to be higher on Tim4+ macrophages which could be linked to the higher 
LDL uptake by those macrophages.  
 
Figure 4.14 Tim4+ ATMs uptaked more LDL and expressed more CD36 
compared to Tim4- ATMs. 
After immune cell isolation from GAT, ATMs were fed with LDL-BODIPY for 2h, 
4h and 6h. ATMs content (left) and CD36 expression (right) were then analysed by 
flow cytometry. A control well was left with no LDL addition. Results represent 1 
experiment with triplicates. 
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4.5 Discussion  
The main results of this chapter are summarised in the table below.   
Table 4-1 Summary of findings from chapter 4  





On cell numbers 
(fold increase) 
8w HFD 14w HFD 
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In this chapter, macrophage heterogeneity in recruitment, sex specificity and 
differences between depots during HFD were highlighted. Males were more 
susceptible to macrophage recruitment than females (Figure 4.3). Macrophage number 
increase during HFD occurred via different mechanisms, with subsets highly 
dependent upon BM derived cells for their expansion and one particular subset, the 
resident population Tim4+, which was increasing in number without any input from 
the BM (Figure 4.6-7). These “true” resident ATMs were notably distinguishable from 
the other cells by their ability to pick up lipids, their high lysosomal content, and their 
MHCII downregulation during HFD (Figure 4.12-13).  
Differences in weight increase between depots 
In this chapter, the comparison of weight and macrophage content between 
GAT and SAT after 8 weeks of HFD showed that GAT was subject to a greater mass 
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increase than SAT, as well as an increase in ATM number, which remained stable 
between lean and obese SAT. These results were similar from those previously 
described in studies including both human and mouse adipose depots (Altintas et al. 
2011; Murano et al. 2008). A lower number of macrophages were found in lean and 
obese SAT, compared to visceral depots (Harman-Boehm et al. 2007). MCP1 (also 
known as CCL2), a potent chemokine regulating monocyte infiltration, increases in 
human omental fat proportionally to weight gain, however, no association has been 
found with the SAT (Harman-Boehm et al. 2007). In mouse, the same relationships 
were observed (Kanda et al. 2006b; Amano et al. 2014). Thus, the current literature 
would suggest that the SAT does not increase MCP1 expression during obesity, 
explaining the minimal macrophage recruitment to this tissue. 
Sex differences in non-host chimerism 
In the GAT, female non-host chimerism within the DN F4/80 high and Tim4+ 
ATM was lower compared to the same subset in the male GAT, in both obese and lean 
mice (Figure 4.4). Gender also influences F4/80high resident macrophage recruitment 
within the peritoneal cavity and kidney (Calum C Bain et al. 2016). In male mice, after 
partial BM chimera, where the peritoneal cavity was protected, the peritoneal 
macrophages normalised non-host chimerism after 9-11 weeks reconstitution was of 
70% whereas in females it was only around 11%. This lower macrophage turnover 
does not have any clear explanation but could be linked with the reproductive organs. 
Indeed, ovaries play a role in macrophage phenotype and number in the peritoneal 
cavity by their hormonal production (notably the 17β-estradiol) (Scotland et al. 2011). 
Surprisingly, in the SAT, female Tim4+ATM non-host chimerism was increased by 
HFD and was even higher than the same population within obese males (Figure 4.4). 
The number of cells for analysis in the SAT was very low compared to the GAT. Cells 
could have been lost, as the SAT was more difficult to digest and seemed to contain 
more “undigested” deposition, maybe reflecting matrix deposition or entities that 
could not be digested by collagenase D. However, Tim4+ macrophages are important 
for apoptotic cell uptake (Miyanishi et al. 2007; Nishi et al. 2014). Female SAT could 
have increased BM derived macrophages that acquire Tim4 in situ to control AT 
inflammation. Thus it could be interesting to measure IL6, IL10 and other cytokines 
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in SAT to compare female and male inflammation status. Moreover, a study showed 
that after 9 weeks of HFD, GAT creates new adipocytes (hyperplasia growth) after a 
hypertrophy phase, while SAT remains with the same number of adipocytes, only 
growing by hypertrophy (Wang et al. 2013). It is possible that in the SAT of females, 
Tim4+ ATMs are necessary to inhibit adipocyte proliferation, as seen with CD206+ 
ATMs in a recent study which shows that these macrophages play a role in the 
modulation of adipocyte progenitors proliferation (Nawaz et al. 2017). 
Tim4+ resident macrophages are outnumbered by BM derived cells 
during obesity. 
This chapter showed that recruited and resident macrophages both coexist in 
the AT tissue of lean and obese mice. If considering the ATM population as a whole, 
during partial BM chimera, lean males had a normalised non-host chimerism in the 
GAT of 39.5%, obese males 71.5%, lean females 22.5% and obese females 34.5% 
suggesting that the contribution of the bone marrow to ATMs increased during obesity 
(Figure 4.5). Tim4+ ATMs were the exception, as this subset showed no significant 
increase in BM input and was proliferating (14%). Amano and colleagues showed that 
4.5% of ATMs in the GAT of obese mice were proliferating vs 1% in the lean GAT 
(Amano et al. 2014). This was shown using a pulse of 5-ethynyl-2′-deoxyuridine 
(EdU), which is incorporated into DNA only exclusively if a cell is in S phase 
(proliferating cells). Previously, a team showed that BrDu incorporation, an alternative 
to Edu, corresponds to Ki67high cells (Jenkins et al. 2013b). In my experiment, I could 
not distinguished high from low Ki67+ ATMs and using Edu or BrDU might be more 
specific. IL6, IL4 and IL13 drives ATM proliferation in AT explants, and could be a 
driver for Tim4 proliferation in vivo (Braune et al. 2017).  
Another group recently used partial BM chimera to study impact of HFD on 
macrophages, but did not see any non-host chimerism increase in GAT macrophages 
after 8 weeks of HFD (1.87%) but rather later. By 12 weeks,  an increase in chimerism 
of 21.66% was found (Zheng et al. 2016b). Their gating was very different of mine as 
they considered macrophages as an homogenous population (F4/80+). Their control 
group also largely increased their non-host chimerism at 12 weeks (14.2% at 12 weeks 
vs 2% at 8 weeks). Moreover the non-host chimerism of blood monocytes seems to 
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vary between groups, as such, normalisation should have been used. As  no statistic 
were showed and it seems that there was no replication of these experiments, it uplifts 
the question of their reproducibility or the trust to have in these results (Zheng et al. 
2016b). However, they did show proliferation (on a group of 3-4 mice) of ATMs 
during HFD.  
Lipid buffering properties of macrophages 
After 8 or 14 weeks of HFD, although all macrophages were able to uptake 
lipids, Tim4+ ATMs were able to internalise more lipids per cell as shown by their 
higher lipid content in both lean and obese AT (Figure 4.10). Furthermore, Tim4+ 
macrophages had increased lysosomal activity, suggesting that these macrophages 
may preferentially degrade the phagocytosed lipids. As they are long lived cells, it is 
possible that Tim4+ ATMs metabolise fatty acids to assure functionality, as shown for 
M2 macrophages (O’Neill, Kishton, and Rathmell 2016). Indeed, M2 macrophages 
preferentially use fatty acid to fuel mitochondrial oxidative phosphorylation which 
leads to ATP production in large quantity (Van Den Bossche, Neill, and Menon 2017; 
O’Neill, Kishton, and Rathmell 2016; Gaber, Strehl, and Buttgereit 2017). 
Lipid buffering by macrophages has also been shown in mice prone to obesity 
(ob/ob mice) after 6 weeks of HFD  (Aouadi et al. 2014). Aouadi and colleagues 
showed that expression of lipoprotein lipase (LpL) by macrophages mediated their 
ability to uptake lipids; silencing LpL reversed lipid accumulation. Other studies using 
also obese ob/ob mice, showed that CD11c+ ATMs have the highest lipid content when 
compared to CD11c- ATMs (Grijalva, Xu, and Ferrante 2016), and that ATMs 
accumulates free cholesterol and saturated triglycerides (Prieur et al. 2011). However, 
in both studies, a global gating on CD11c- might have hidden the importance of 
Tim4+ATMs in lipid uptake. Our results suggested that the longer the mice were on 
HFD the more CD11c+ ATMs increases their lipid content. This might be due to the 
fact that Tim4+ ATMs were overloaded and not able to increase in number 
proportionally with the increase of lipids to buffer in the tissue. It would be interesting 
to study if Tim4 ATMs produce cytokines dictating recruitment of monocytes in the 
tissue. 
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Tim4+ ATMs seemed able to uptake more LDL than other macrophages in vitro 
and expressed more CD36 (Figure 4.14). A study from 2009 showed that F4/80high 
ATMs express the peroxisome proliferator-activated receptor γ (PPAR γ) and CD36 
in large quantity, combined with a higher number of SSC-Ahigh cells (Bassaganya-
Riera et al. 2009). These data and the data presented in this chapter suggest that 
F4/80high, which includes the F4/80highTim4+ ATMs, have a greater capacity to uptake 
and metabolise lipids. Indeed, PPAR γ is a transcription factor which induce CD36 
and increases oxidized low density lipoproteins (oxLDL) uptake by macrophages 
(Tontonoz et al. 1998). A specific deletion of PPARγ in macrophages, thus a decrease 
in CD36 expression, increases weight gain and insulin resistance in mice (Odegaard et 
al. 2007). Therefore macrophage ability to uptake lipids is important to maintain body 
lipid and glucose homeostasis during HFD. Tim4 ATMs could be a central actor in 
these processes. 
Tim4, inflammation silencer ? 
CD11c+ ATMs have been linked to AT inflammation (Patsouris et al. 2008a; 
Carey N Lumeng, Bodzin, and Saltiel 2007; M. T. A. Nguyen et al. 2007). HFD 
markedly increases their number in the tissue within crown like structures around 
dying adipocytes, and has been linked with pro inflammatory gene expression (John 
M Wentworth et al. 2010; Patsouris et al. 2008b; Carey N Lumeng, Bodzin, and Saltiel 
2007). In this study, the CD11c+ ATMs which were uptaking lipids expressed high 
levels of MHCII, whereas the Tim4+ ATMs which were uptaking lipids expressed low 
levels of MHCII. CD11c+ ATMs might be associated with antigen presentation, after 
lipid engulfment, to T cells and thus could promote their proliferation. ATMs, and 
notably CD11c+, have been linked with interferon-γ-producing CD4 T cell 
proliferation during HFD (Morris et al. 2013). In contrast, Tim4+, which seem to 
partially downregulate MHCII might act as inflammation silencer. In the context of 
cancer, tumor associated macrophages expressing Tim4 are able to phagocytes dying 
cells and decrease antigen presentation following Tim4 uptake of dead tumor cells 
(Baghdadi et al. 2013). Indeed they showed that Tim4 induces autophagic vesicles that 
“over-digest” any left particles which has for effect to reduce antigen presentation 
(Baghdadi et al. 2013). Tim4 intervention in removing apoptotic cells appears to be 
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finely controlled. Indeed, directed apoptotic cells clearance through Tim4 expressing 
cells rather than recruited inflammatory monocytes controls inflammation (Uderhardt 
et al. 2012). They showed that if Tim4 macrophages in the peritoneal cavity sequester 
MFG-E8 (milk fat globule E8), which is a molecule “adapter” between PS and 
macrophages that do not express Tim4. By sequestering MFG-E8, Tim4+ macrophages 
rend impossible for inflammatory macrophages to uptake dying cells which in turn 
reduce inflammation (Uderhardt et al. 2012). A recent study showed that a new class 
of ATM BM derived CD9+ are lipid laden but have a pro-inflammatory phenotype (D. 
A. Hill et al. 2018). In contrast, Tim4 might have an anti-inflammatory phenotype. 
Conclusion 
Tim4 is a new subset of ATMs, which increase in number by proliferation 
rather than recruitment. However BM derived ATMs outnumber them during obesity. 
Since this subset had a higher amount of lipids and lysotracker compared to other 
macrophages, and seemed better at uptaking LDL, I then choose to study how Tim4 













CHAPTER 5 TIM4 BLOCKADE REDUCES LIPID 
UPTAKE AND LYSOSOMAL ACTIVITY OF TIM4+ 
ATMS  





The ATMs micro-environment is quite singular due to their lipid rich 
neighbours: the adipocytes. During fasting periods, adipocyte lipolysis is activated in 
order to release energy (free fatty acids) to other tissues by lysis of their triglyceride 
(Stern, Rutkowski, and Scherer 2016). Local lipid influxes are then increased and lipid 
laden macrophages are found in the AT (Kosteli et al. 2010a). During obesity, there is 
an increase in basal rates of lipolysis, as the tissue become insulin resistant and 
dysfunctional, which increases the number of lipid laden macrophages in the tissue 
(Duncan et al. 2007). Notably, the pro-inflammatory CD11c+ ATMs were found to 
have a higher lipid content compared to CD11c- cells (Carey N Lumeng, Bodzin, and 
Saltiel 2007). Fast and obesity are opposite states but in both cases macrophages seem 
to be able to respond to lipid availability in the tissue. In addition to simply containing 
lipids, ATMs have the ability to activate a lysosomal program which can cause lipid 
catabolism (X. Xu et al. 2013). Blocking lysosomal activity, using chloroquine, a drug 
which penetrates the lysosomes and inhibits their acidification, resulted in an increase 
in ATM lipid content and a decrease in net free fatty acid release by the AT in vitro 
(X. Xu et al. 2013). However, chloroquine targets all macrophages, so it is unclear if 
all macrophages are able to release FFA or if it is subset specific. Excessive release of 
FFA by AT to the liver and elevated triglyceride and LDL cholesterol are key features 
of obesity, and concomitantly increase the risk of cardiovascular disease  (Klop, Elte, 
and Cabezas 2013). Lowering plasma LDL, using commercially available drugs, or 
reducing FFA levels in the plasma is sufficient to improve insulin resistance (Boden 
2008). The fact that ATMs are involved in FFA release could potentially lead to the 
development of new drugs to lower the lipid content of the plasma (X. Xu et al. 2013). 
In the previous chapter, Tim4 ATMs were found to have the highest lipid content, the 
highest lysosomal content and also a greater ability to pick up LDL compared to other 
ATMs. This indicates that Tim4+ ATMs are well equipped to perform lysosomal 
lipolysis and predicts the involvement of these cells in FFA release during HFD 
challenge. Importantly, several genome wide association studies (GWAS) have shown 
an association between timd4, the gene encoding TIM4, with blood lipid content 
(cholesterol, LDL, TG) (Kathiresan et al. 2009b; Teslovich et al. 2010; Do et al. 2013; 
Surakka et al. 2015). Nonetheless, the role of Tim4 has never been discussed in the 




setting of HFD and obesity. Thus, I hypothesised that, out of all ATMs, Tim4+ ATMs 
are the subset of macrophages controlling FFA in the plasma during HFD challenge.  
5.2 Aim 
In the previous chapters of this thesis, a resident population Tim4+ was 
characterised which seemed to contain more lipids and lysosomes than the other 
macrophages, notably in lean and at the early onset of obesity. Since ATMs were 
shown to be involved in lipid metabolism, due to lipid degradation via their lysosomes, 
the aim of this chapter is to test the hypothesis that Tim4+ macrophages are the subset 
of ATMs that specifically control lipid metabolism and participate in FFA release into 
the bloodstream. To do this, experiments were performed as follow : 
 In vivo blockade of Tim4 to study its impact on FFA in the blood and other 
metabolic parameters such as glucose tolerance.  
 In vitro blockade of Tim4 to study the role of Tim4 in lipid uptake and 
lysosomal activation. 
5.3 Experimental design 
To study the impact of the phosphatidylserine receptor Tim4, in vivo blockade 
of Tim4 was carried out as shown in Figure 2.3. Eight week-old C57BL/6 males were 
placed on either HFD or control diet (CD) for 8 weeks. After 4 weeks of diet, mice 
from both groups were i.p. injected twice a week for the rest of the experiment with 
100µl of PBS containing either 200ng of blocking anti-Tim4 IgG2a or 200ng of 
isotype IgG2a control. During the last week of the diet, an oral glucose tolerance test 
was performed and the mice were culled 2 days later. For short term HFD challenge, 
mice were only injected once with either anti-Tim4 IgG2a or isotype IgG2a control 
the day before the start of the diet (D0), then placed on either CD or HFD for an 
additional 3 days (Figure 1.1B).  





Figure 5.1 Experimental design of Tim4 blockade during long (A) and short HFD 
(B) 
Male mice were given a HFD for 8 weeks (w: weeks) or for a shorter period of time 
(D: day). A After 4 weeks of diet, mice from both groups were i.p. injected twice a 
week for the rest of the experiment with 100µl of PBS containing either 200ng of 
blocking anti-Tim4 IgG2a or 200ng of isotype IgG2a control (plain arrow). An oral 
glucose tolerance test (OGTT) was performed 2 to 3 days before the cull. B Short HFD 
with injection of 100µl of PBS containing either 200ng of blocking anti-Tim4 IgG2a 
or 200ng of isotype IgG2a control (plain arrow) 
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5.4.1 Impact of in vivo Tim4 blockade with monoclonal 
antibodies on macrophages 
To study the impact of Tim4+ macrophages on lipid homeostasis, mice were 
injected (i.p.) twice a week, from week 4 to the cull, with a monoclonal IgG2a antibody 
against Tim4 (aTim4). Control mice were injected with IgG control antibodies 
(Isotype) (Figure 2.3). Flow cytometry analysis of CD45+F480+ cells in the GAT and 
the peritoneal exudate cells (PEC) showed that injection of anti Tim4 antibody totally 
blocked its recognition by flow cytometry in the GAT (Figure 5.2, upper graph) but 
not totally in the PEC (Figure 5.2, lower graph) where some cells were still presenting 
Tim 4 at their surface, even if the intensity was decreased. Few F4/80-CD11b- cells 
expressing Tim4 and MHC-II, probably dendritic cells, were also blocked in this 
process. But their number in AT was very low (data not shown).  
 
Figure 5.2 Tim4 blockade twice a week for 4 weeks during a long HFD blocked 
Tim4 in ATMs but only partially in the PEC  
Mice were fed ad libitum  either control diet or a HFD for 8 weeks and injected (200 
ng i.p) with an isotype control or an anti-Tim4 (aTim4) blocking antibody as shown in 
Figure 2.3A. Flow cytometry analysis on GAT and peritoneal exudate cells showed 
Tim4 expression on CD45+Lin-F4/80+ cells at the time of the cull. Images 
representative of 1 experiment (n=5 per group).  




5.4.2 Impact of in vivo Tim4 blockade coupled to long term 
HFD 
Tim4 blockade had no effect on body and GAT weight 
To study the impact of Tim4+ macrophages on lipid homeostasis during 
obesity, mice were given HFD composed of 60% fat (Reseach Diet) and were injected 
(i.p.) twice a week, from week 4 to the cull, with a monoclonal IgG2a antibody against 
Tim4 (aTim4). Control mice were injected with IgG control antibodies (Isotype) 
(Figure 2.3). After 8 week of HFD, mice gained a significant amount of body weight 
and had a higher GAT fat mass compared to controls. The aTim4 treatment had no 
impact on weight gain.  
 
Figure 5.3 Weight gain and GAT weight of C57BL/6 male mice fed a control diet 
or a HFD for 8 weeks, with or without Tim4 blockade. 
Mice were fed ad libitum  either control diet or a HFD for 8 weeks and injected (200 
ng i.p) with an isotype control or an anti-Tim4 (aTim4) blocking antibody as shown in 
Figure 2.3A. 
Percentage of weight gain is shown in (A) and weight of the GAT is shown in (B) Data 
are representative of 2 experiments.  Each data point represents a mouse and the 
column the mean. Two-way-Anova was performed ***: p<0.001.  
  




Tim4 blockade had no impact on glucose tolerance 
 After 8 weeks of diet, an oral glucose tolerance test (OGTT) was performed. A 
bolus of glucose (2mg/mg of body weight) was given by gavage to each mouse. Before 
the glucose gavage (T0) and after 15, 30, 60, and 120 minutes, a sample of blood was 
taken from the tail to measure glucose levels. The glucose levels at T0 were not 
significantly different between diets and treatments. However, levels of plasma 
glucose at T15 were higher in HFD fed mice compared to the controls. Moreover, the 
overall plasma glucose levels measured by area under the curve was increased during 
HFD compare to controls. However, Tim4 blockade had no impact on glucose 
intolerance.  
 
Figure 5.4 Plasma glucose level after administration of a glucose bolus to mice fed 
a control diet or a HFD for 8 weeks, with or without Tim4 blockade. 
Mice were given a control diet or a HFD for 8 weeks and injected (200 ng i.p.) with a 
isotype control or an anti-Tim4 (aTim4) antibody as shown in Figure 2.3A. At the 8th 
week of diet, a bolus of glucose was given by gavage to the mice (2mg/gram of body 
weight) to perform an oral glucose tolerance test (OGTT). (A) Plasma glucose levels 
(mmol/L) measured in plasma 15, 30, 60, 90 and 120 minutes after gavage(B) Area 
under the curve of glucose levels during OGTT was measured (0 being the baseline). 
Data are represented as mean ± SEM (2 independent experiments, n=5 per group per 










































CD + a i
HF  + Isotype
HF   a im4




In vivo Tim4 blockade decreased free fatty acid in the plasma of obese 
mice after 8 weeks of HFD 
 FFA in the plasma was measured on blood withdrawn from mice just before 
cull (non-fasted mice). Eight weeks of HFD significantly increased FFA in the plasma 
compared to control mice, however mice treated with aTim4 antibodies had lower FFA 
levels than control mice (Figure 5.5), thus indicating that Tim4 was involved in lipid 
metabolism during HFD challenge.  
  
 Figure 5.5 FFA levels in plasma of mice fed a HFD for 8 weeks was 
decreased by aTim4 treatment.  
Mice were given a control diet or a HFD for 8 weeks and injected (200 ng i.p.) with a 
isotype control or an anti-Tim4 (aTim4) as shown in Figure 2.3A. FFA was measured 
in the plasma. Data pooled from 2 independent experiments (n=4-5 per group per 
experiment). Each dot represents a mouse and the mean is represented by the black bar 
























HFD led to increased lysosomal activity in Tim4+ ATMs and blocking 
Tim4 abrogated lysosomal activity 
  In a previous study by Xu et. al, a macrophage lysosomal program was 
observed to be activated after HFD feeding, which the authors concluded was 
responsible for the release of FFA by macrophages, following lipid degradation within 
the lysosomes (X. Xu et al. 2013). As blocking Tim4 reduced FFA level in the serum 
(Figure 5.5), I next assessed the lysosomal activity of Tim4+ macrophages. Injection 
of anti-Tim4 antibodies was not targeting adipose macrophages specifically, and other 
Tim4+ macrophages could be targeted (Figure 5.2). Indeed, Tim4+ is expressed by 
resident  peritoneal cavity macrophages, resident Kuppfer cells in the liver. Since 
Kupffer cells,  are the largest resident population in the body (Miyanishi et al. 2007; 
Zigmond et al. 2014; Nishi et al. 2014), it was critical to assess if the diet and/or Tim4 
blockade could impact lysosomal activation in this important macrophage population. 
To look at lysosomal activity and assess the impact of Tim4 blockade, macrophages 
from GAT, peritoneal lavage and liver were taken after 12-14 weeks of HFD. After 
purification of macrophages by adhesion method, cells were stained with lysotracker 
to quantify lysosomal activity within Tim4+ cells after 6h in culture. HFD led to an 
increase of lysosomal MFI in Tim4+ ATMs (Figure 5.6). This increase was unique to 
ATMs as no changes were observed in Tim4+  macrophages from the liver or the PEC 
due to HFD. However, Tim4 blockade decreased lysotracker MFI in both control and 
high fat fed mice, and this occured independently from macrophage tissue origin 
(Figure 5.6). Therefore the main effect of Tim4 was to decrease lysosomal activity in 
all tim4 expressing macrophage populations assessed.  
  





 Figure 5.6 Tim4 blockade decreased lysotracker MFI in Tim4+ macrophages 
from the GAT, PEC and liver, in both lean and obese mice (8 weeks HFD). 
Tim4 blockade was achieved as shown in Figure 2.3A. After adhesion-purification, 
macrophages were stained with lysotracker (500nM). Images were acquired using a 
Leica SP5 confocal microscope and the mean fluorescence intensity was quantified for 
each Tim4+ macrophage population, either blocked with aTim4 or not. The bar 
represent the mean intensity. Each dot represent one Tim4+ macrophage. One Way 
Anova was performed. *: p<0.05; **: p<0.01; ****: p<0.0001. 
 
Tim4 blockade decreased LDL uptake by adipose, PEC and liver Tim4+ 
macrophages 
 As Tim4 blockade reduced lysosomal activity in macrophages 
extracted from both lean and obese mice, I then compared the ability of Tim4+ 
macrophages from AT, liver and PEC to uptake lipids, specifically low densitiy 
lipoproteins (LDL). LDL are lipoproteins composed mainly of cholesterol. LDL, 
coupled with Bodipy (a fluorescent dye), was added for 6h to wells containing 
adhesion purified macrophages isolated from the GAT, PEC and liver of either lean or 
obese mice (12-14 weeks of HFD), and blocked or not with aTim4 in vitro. Images 
were taken by confocal microscopy (Figure 5.7) and LDL and lysotracker fluorescence 
intensities were quantify for each cells (Figure 5.8 and Figure 5.9). By adding LDL in 
the wells, macrophages increased their lysosomal activity as seen by the increase in 
lysotracker intensity in the control and HFD groups. However, this was not observed 
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Figure 5.7 LDL uptake by ATMS seen by confocal microscopy (x100) 
LDL- Bodipy was added for 6h to wells containing plate purified macrophages isolated 
from the GAT then stained with Lysotracker (lysosomes) and Tim4. This is a 
representation of ATMS from obese mice (12-14 weeks of HFD). Scale bar 10µm.  
 
 
Figure 5.8 Lysotracker was increased in Tim4+ ATMS by addition of LDL only 
when the receptor was not blocked 
Tim4 blockade was performed as shown in Figure 2.3A. After adhesion-purification, 
macrophages were cultured with LDL-Bodipy for 6h (50µg/ml) and stained with 
lysotracker (500nM). Images were acquired using a Leica SP5 confocal microscope 
and the MFI was quantified for individual Tim4+ macrophages, either blocked with 
aTim4 or not. Bars represent the mean intensity. Each dot represents one Tim4+ 
macrophage. Reprensentative of 1 experiment. Student t test ****: p<0.0001. 
 




The ability of Tim4+ macrophages to uptake LDL was increased in ATMS of 
obese mice compared to lean mice (Figure 5.9 A, left). In contrast, there was a 
significant deficit in the ability of liver macrophages purified from obese animals to 
acquire LDL in vitro compared to liver macrophages isolated from the livers of lean 
mice. However, there was a striking increase in lysotracker activity within 
macrophages isolated from both GAT and liver of obese mice compared to lean 
controls (Figure 5.9 B). Tim4+ macrophages from the PEC did not increase their ability 
to uptake lipid nor to activate their lysosomes following HFD feeding (Figure 5.9 A-
B). Remarkably, Tim4 blockade  consistently decreased LDL uptake and lysotracker 
intensity in all tissues selected, independently of the diet (Figure 5.9 A-B). 
Since I found that a short in vitro blockade impacted lipid uptake and lysosomal 
activity, I then assessed the impact of a short in vivo blockade associated with a short 
HFD to mimic an excessive lipid rich meal.  
  





 Figure 5.9 Tim4 blockade reduced LDL uptake (A) and lysotracker MFI (B) in 
Tim4+ macrophages from the GAT, PEC and LIVER, both in lean and obese mice 
fed a HFD for 12-14 weeks.   
Tim4 blockade was performed as shown in Figure 2.3A. After adhesion-purification, 
macrophages were cultured with LDL-Bodipy for 6h (50µg/ml) and stained with 
lysotracker (500nM). Images were acquired using a Leica SP5 confocal microscope 
and the MFI was quantified for individual Tim4+ macrophages, either blocked with 
aTim4 or not. Bars represent the mean intensity. Each dot represents one Tim4+ 
macrophage. One Way Anova was performed for statistical analysis. *: p<0.05; **: 
p<0.01; ****: p<0.0001. 
 
  




5.4.3 Impact of in vivo Tim4 blockade coupled to short term 
HFD 
Interestingly, short term HFD, as little as 3 days, can increase the number of 
macrophages in the visceral AT and increase glucose intolerance, which could be 
easily reproduced by human by a large lipid rich meal or couple of days of lipid rich 
food (Lee et al. 2011). As 8 weeks of HFD only influenced the levels of plasma FFA 
and did not alter glucose tolerance, it was interesting to determine if this impact was 
dependent of the length of diet or simply the presence of a high fat meal. Mice were 
given HFD for 3 days or 1 day, with 1 injection of aTim4 at D0 or D-1 respectively.  
Blocking Tim4 decreased FFA in the plasma after a short HFD  
After 3 days of HFD, mice showed increased level of FFA in the plasma 
compared to the control mice. Tim4 blockade led to a noticeable decrease in FFA 
levels in HFD fed mice but this failed to reach significance (p=0.056) (Figure 5.10 A).  
 
Figure 5.10 Tim4 blockade decreased FFA in the plasma of mice fed a HFD for 3 
days compared to mice injected with isotype 
Mice were given a control diet or a HFD for 3 days with or without Tim4 blockade, as 
shown in Figure 2.3. The free fatty acid in the plasma was measured in non-fasted 
mice  using WAKO kit (µEq/L). Data grouped from 3-4 independent experiments (n=5 
per group per experiment). Two-way-Anova was performed for statistical analysis : 


















As the Tim4 treatment tended towards a decrease in FFA in the blood of HFD mice 
compared to untreated controls, independently of the length of the diet (8 weeks and 3 
days), I then hypothesised that the blocking impact might be due to the meal itself and 
not the length of the diet. 
One day of HFD was sufficient to increase FFA in the blood and was 
blocked by Tim4 blockade.  
Mice were given a single day of HFD; mice were given access to HFD ad 
libitum at 3pm and culled the next day at 9am prior to assessment of FFA in terminal 
blood. One day of HFD was sufficient to increase FFA in the blood, however Tim4 
treatment lowered this effect neatly (Figure 5.11). 
 
Figure 5.11 Tim4 blockade decreased FFA in the plasma of mice fed 1 day of  
HFD compared to mice injected with isotype control 
Mice were given a control diet or a HFD for 3 days with or without Tim4 blockade, as 
shown in Figure 2.3. The free fatty acid in the plasma was measured in non-fasted 
mice  using WAKO kit (µEq/L). Data grouped from 2 independent experiments for 
the HFD group (n=5 per group per experiment) and 1 experiment for the control group. 
Two-way-Anova was performed for statistical analysis : *: p<0.5; ***: p<0.001  
 
As FFA was decreased, macrophages taken from these mice were analysed to 























One day of HFD increased lipid content in Tim4+ ATMs and was sufficient 
to increase FFA in the blood; this increase was inhibited by Tim4 
blockade.  
As 1 day of HFD significantly reduced FFA in the plasma, lipid content and 
lysosomal activity of macrophages from these mice were also analysed after adhesion 
mediated purification. One day HFD increased neutral lipid content in GAT, PEC but 
not liver Tim4+ macrophages (Figure 5.12A). This increase was blocked by Tim4 
blockade. Surprisingly, I found that 1 day HFD decreased lysosomal activity in GAT 
and liver (Figure 5.12B). Tim4 blockade decreased lysosomal activity in all tissues 
and for each diet.  
 
Figure 5.12 Tim4 blockade on Tim4+ macrophages from GAT, PEC, and Liver 
decreased lysotracker MFI in all groups independently of the diet and decreased 
lipid content in the GAT (control and HFD), and the PEC (HFD only).  
Tim4 blockade was realised as shown in Figure 2.3. After adhesion-purification, 
macrophages were stained with lysotracker (500nM) and lipidtox. Images were 
acquired using a  Leica SP5 confocal microscope and the MFI was quantified for each 
Tim4+ macrophage, either blocked with aTim4 or not. Bars represent the mean 
intensity. Each dot represents one Tim4+ macrophage. One Way Anova was performed 
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5.4.4  Lysotracker intensity and lipid uptake was correlated 
with Tim4 intensity on ATMs after being fed with 
chylomicrons 
To test the ability of macrophages to uptake lipids other than LDL, 
macrophages from the GAT and PEC were exposed to chylomicrons (CM) after, or 
not, in vitro Tim4 blockade. The media used was serum free so the only fatty acids 
found or lipids would be coming from the CM and intracellular lipids. CM composition 
is very different from LDL, as they contain triglycerides at a high level and only a few 
molecule of cholesterol. As the CM used were not coupled with a dye, LipidTox 
Neutral lipid staining was added to stain lipids contained within the cells following 
fixation. Therefore, this staining was not specific to CM and included endogenous 
lipids already present within the cells. Adding CM increased the lipid content of Tim4+ 
ATMs as seen by the increase of LipidTox MFI (+42) when compared to control 
macrophages that were not exposed to CM (Figure 5.13A). Nonetheless, CM had no 
impact on Tim4+ PEC lipid content. Therefore, CM uptake was more specific to Tim4+ 
ATMs. CM uptake by ATMs was accompanied by an increase in lysosomal activity 
(+15) (Figure 5.13B). Tim4 blockade decreased lipid content within ATMs and 
reversed the lysosomal activity increase caused by addition of CM (Figure 5.13A-B).  
  





Figure 5.13 Tim4 blockade decreased lipid uptake and lysosomal activity in the 
GAT but not in the PEC macrophages 
After purification of macrophages by adhesion method on a coverslip, macrophages 
from the GAT or the PEC were blocked or not with anti-Tim4 antibodies. Then they 
were given chylomicrons (83µg/ml) for 3h at 37°C. The cells were stained with 
Lipidtox (A) and lysotracker (B). The white number in columns represents the absolute 
difference between the control column with no CM, only if the difference reached 
significance (indicated above the column). One way anova was performed for 











Moreover, statistical linear regression showed that the amount of lipids and 
lysotracker was positively correlated to Tim4 MFI after CM challenge. A weak 
positive correlation (R2 = 0.28) existed between the amount of lipids inside 
macrophages and the presence of Tim4 (Figure 5.14A). This relationship was almost 
cancelled by Tim4 blockade (R2 = 0.07) (Figure 5.14B). A moderate correlation 
existed between lysotracker MFI and Tim4 MFI (r2>0.50) which became weaker with 
Tim4 blockade ( r2=0.14) (Figure 5.14 A-B). To conclude, Tim4 seemed to be 
moderately linked with lipid uptake and more strongly with lysosomal activity.  
 
Figure 5.14 Tim4 correlates positively with lysotracker and lipidtox content after 
chylomicron challenge.  
After purification of macrophages by adhesion method on a coverslip, macrophages 
were blocked or not with anti-Tim4 antibodies. Then they were given chylomicrons 
(83µg/ml) for 3h at 37°C. The cells were stained with lysotracker (lysosomes) and 
lipidtox (Lipid). Lipid content and lysotracker was measured in each F4/80+ 
macrophage (MFI) and correlated to Tim4 intensity non-blocked (A) and blocked (B) 
conditions. Pearson product-moment correlation (R2) and the P value were calculated 
























































In this chapter, I analysed the impact of Tim4 blockade on lipid handling. The main 
results are presented in the table below (Table 5-1). 
Table 5-1 Summary of findings from chapter 5 
 Tim 4 blockade (compare to control) 




Glucose tolerance Unchanged N/A N/A 
FFA (blood)  Decreased Decreased N/A 
Lipid 
content 
GAT N/A Decreased Decreased 
PEC N/A Decreased Decreased 




GAT  Decreased Decreased Decreased 
PEC Decreased Decreased Decreased 
LIVER Decreased Decreased Decreased 









CM uptake GAT N/A N/A Decreased+ 
lyso. decreased 
PEC N/A N/A No effect 
 
  




Lysosomal activity during HFD 
In the present study, following 14 weeks of HFD, lysosomal activity in Tim4+ 
ATMs was increased (Figure 5.6). A previous study demonstrated that HFD increased 
lysosomal activity in ATMs and its inhibition (using chloroquine) increased lipid 
content in ATMs (X. Xu et al. 2013). To add, they also showed that blocking lysosomal 
activity decreased the release of FFA from fat tissue in vitro. In this chapter, long and 
short term Tim4 blockade reduced the amount of lysosomal activity and was 
accompanied by a decrease of FFA levels in the plasma of mice. This decrease was 
not accompanied by an improvement of glucose tolerance (OGTT) (Figure 5.4). 
Insulin levels were not measure in these experiments but could be a further indication 
of the general metabolic states of mice, notably if the mice developed insulin resistance 
(Boden 2008). Moreover, more lipids could be measured in the blood, notably levels 
of LDL and cholesterol, which were correlated with timd4 SNP in genome wide 
association studies in human (Kathiresan et al. 2009a).  
ATMs accumulate lipids after 1 day of HFD however, I did not find any sign 
of lysosomal activation (Figure 5.12), which could mean that increase of lysosomal  
activity in ATMs might take several days or weeks to take place. However, caution 
must be used in the interpretation of the data  as I encountered some technical 
challenges in the design of this experiment. The first technical challenge to overcome 
would be to control the timing of the last meal eaten by the mice prior to harvest. For 
all experiments, mice were culled at the same period of time (between 9 am and 10am), 
and the mice were not fasted beforehand as fasting can also increase lipolysis and lipid 
uptake by macrophages (Kosteli et al. 2010b). However, depending on mice, it is 
possible that some differences between the last meal and the time of the cull occurred. 
The use of metabolic cages would be interesting to follow the overall mice activity per 
hour and track the food and water intake, the physical activity, O2 consumed and CO2 
produced. Secondly, Tim4 macrophages are charged with lipids. This can potentially 
make them less dense and result in floatation during the cell preparation as observed 
in other studies for F4/80+ macrophages (Weisberg et al. 2003; X. Xu et al. 2013). A 
preliminary experiment showed that indeed, Tim4+ macrophages and F4/80high 
macrophages were found in the floating fraction of adipose digest and both represented 
around 40% of CD45+. The floating fraction could not be analysed during long HFD 




due to the amount of lipids present in the fraction that rendered impossible flow 
cytometry analysis.  
Tim4 and lipid uptake  
Blocking Tim4 blocked LDL (Figure 5.9) and CM uptake (Figure 5.13). This 
explains the decrease in lysotracker staining as macrophages were not able to pick up 
more lipids. The source of lipids present in Tim4+ ATMs could be various. Firstly,  
Tim4 could participate in the engulfment of apoptotic adipocytes through the 
recognition  of PS on dead cells (Miyanishi et al. 2007; Kobayashi et al. 2007; K. 
Wong et al. 2010). Secondly, PS are found on the surface of lipid particles. Indeed 
phospholipids are hydrophilic and are at the surface of the lipoprotein to encapsulate 
hydrophobic lipids, allowing transport in the circulation (Feingold and Grunfeld 
2000). Tim4 could participate in the recognition and uptake of excess PS+ lipid 
particles coming from the bloodstream and that can’t be picked up by adipocytes after 
a fat rich meal. In this chapter, it was demonstrated that compared to the PEC, Tim4+ 
ATMs had a higher affinity for CM (Figure 5.13) which could suggest that Tim4+ 
ATMs are specialised in the uptake of CM when the AT is saturated as happens after 
a HFD meal. Shin et al. showed that very low density lipoprotein receptor (VLDLR) 
mRNA expression is increased in ATMs with HFD, but no increase in LDLR is 
observed (Shin et al. 2017). VLDLR is involved in CM metabolism and would explain 
the affinity of ATMs with CM but further analysis would be required (Goudriaan et 
al. 2004).  
It is possible that after Tim4 recognises phospholipids , it allows its uptake to 
the lysosome and its degradation. Analysis of images taken with confocal microscope, 
such as in Figure 5.7, suggesting that Tim4 colocalised with lysosomes. The same 
observation was done in a study where the authors showed that Tim4 colocalised with 
Lamp1+ phagosomes after apoptotic tumour engulfment (Baghdadi et al. 2013). They 
further showed that Tim4 phagocytic activity was linked to an AMPK pathway. More 
images need to be analysed with higher resolution to confirm these results, but Tim4 
seem to carry lipids to the lysosomes via translocation. The mechanisms linked with 
Tim4 are still not fully understood. Tim4 could act as a tethering receptor, with no 
direct signalling to the cell, and might rely on other surface receptor to assure its 




phagocytic role (Park, Hochreiter-Hufford, and Ravichandran 2009). However 
Baghdadi et al. suggested that Tim4 mediates an AMP-activated protein kinase 
(AMPK) activation (Baghdadi et al. 2013). AMPK is a known activator of 
transcription factor regulating lysosomal and autophagic genes (Hipolito, Ospina-
Escobar, and Botelho 2018). Therefore, Tim4 might upregulate indirectly lysosomal 
synthesis.  
Tim4+ macrophages from different tissues don’t show the same affinity 
to lipids  
Here, I demonstrated that ATMs, PEC and Liver have various affinity to lipids 
(LDL or CM) and various associated lysosomal activities and particularly that . Tim4+ 
ATMs had a higher lysotracker intensity compared to PEC and liver, in lean mice (data 
not shown). This stresses the importance on analysing “real life” tissue macrophage 
populations and highlights the limitations of the use of PEC or bone marrow derived 
macrophages to illustrate mechanisms relating to a specific organ as environment can 
prime microphages to express certain receptors more than others. For example in the 
study of Shin et. al in 2017 about VLDLR, they characterised the receptor on ATMs 
but they used PEC and BMDM to study the impact of VLDL on cytokines production 
and inflammation (Shin et al. 2017). Some authors highlighted the difference between 
PEC and ATMs by looking at gene expression and linked obesity with a metabolic 
activation in ATMs but not in PEC (Boutens et al. 2018). This could explain the 
differences in lysotracker activity (Figure 5.6) and LDL uptake (Figure 5.9) during 
long term HFD. At homeostasis, Tim4+ ATMs are naturally dealing with lipid spill-
over and lipid influxes from  adipocytes, which is increased by HFD or fasting (Kosteli 
et al. 2010a; C. N. Lumeng et al. 2007). In the same way, Kupffer cells are also in 
contact with lipids as the liver synthesises VLDL, but also have receptors for molecule 
rich in cholesterol such as LDL and HDL (Krenkel and Tacke 2017; Remmerie and 
Scott 2018). Kupffer cells are indeed enriched in genes involved in cholesterol 
metabolism (Scott and Guilliams 2018). In the liver, recruited macrophages 
accumulate lipids coming from oxLDL within their lysosomes. These macrophages 
generate hepatic inflammation and fibrosis which are linked with the promotion of 
non-alcoholic liver diseases (Houben et al. 2017). The role of Tim4+ macrophages in 




this context needs to be explored as they might have higher lysosomal capacity of 
degradation and do not accumulate lipids. Acute HFD is sufficient for liver to 
accumulate lipids, to induce hepatic insulin resistance (Samuel et al. 2004) and AT 
inflammation (Lee et al. 2011) so it could be an easy and good model to study Tim4 
blockade. The intestines also contains Tim4 resident  macrophages (Shaw et al. 2018). 
This organ is particularly involved with lipid handling and release FFA to the portal 
circulation as well as liposaccharides from its microbiota. The gut microbiota is 
heavily influenced by diet (Konrad and Wueest 2014) and only few days after a change 
of diet, the microbiome can be changed (David et al. 2014). The impact of Tim4 
blockade on this organ could be useful to understand inflammation but also how lipid 
availability can be altered if Tim4 is blocked and how it could impact bacteria. 
Conclusion  
Tim4 capacity to engulf apoptotic cells have been largely explored. However, 
Tim4 signalling is not very clear. Here, I found a novel role for this PS receptor, 
notably in lipid handling. Tim4 is involved in lipid and lysosomal degradation of 
lipids, and the release of FFA in the bloodstream in vivo. This leads to more questions 
about the mode of action and the exact nature of the lipids that Tim4 is up taking. As 
Tim4 is also present in the gut, which is a hub for dietary lipid absorption and 
chylomicrons synthesis, it would be interesting to study the impact of Tim4 blockade 





CHAPTER 6 TIM4+ MACROPHAGES ARE 
PRESENT IN HUMAN ADIPOSE DEPOTS  




The World Health Organisation recognised that in 2016, 650 millions of adults 
were obese (“WHO | Obesity and Overweight” 2018). A body mass index (BMI) 
superior to 30 kg/m2 is an indicator of obesity, however fat distribution is also an 
important factor, as measured by the waist to hip ratio (WHR). The “pear shape” 
characterises people with WAT accumulation around the hips, in the subcutaneous 
depot, while the “apple shape” is a central accumulation, in the visceral AT. After 
being adjusted to the BMI, central WAT accumulation, otherwise said VAT 
accumulation in the abdomen, is more often associated with chronic diseases such as 
type 2 diabetes and cardiovascular diseases (Matsuzawa et al. 1995; Fu, Hofker, and 
Wijmenga 2015). A ratio above 0.85 in woman and 0.90 in man defined obesity 
according to the World Health organisation (“WHO | Waist Circumference and Waist–
Hip Ratio” 2018). Accumulation of macrophages in the visceral depot, the main depot 
being called omentum in human, is a feature of obesity (Weisberg et al. 2003; H. Xu 
et al. 2003). The accumulation of ATMs in the omentum and subcutaneous AT is 
positively associated with insulin resistance and AT inflammation (Koppaka et al. 
2013; Cinti et al. 2005; John M Wentworth et al. 2010). Early study described the 
presence of lipid laden CD14+CD64+ ATMs around apoptotic adipocytes, in “crown 
like structures” (CLS) (Cinti et al. 2005). Later, CD14+CD11c+ proinflammatory 
ATMs were also found in human AT and were particularly expressed by ATMs within 
CLS (John M Wentworth et al. 2010). The quest to understand ATM biology during 
obesity led to the discovery of macrophages alternatively activated in high numbers in 
obese AT, such as CD163+ ATMs (scavenging receptor), but also CD206+ ATMs 
(mannose receptor) (Kristiansen et al. 2001; John M Wentworth et al. 2010; Fjeldborg 
et al. 2014). The presence of subsets that can have different functions in human AT 
has to be investigated further. My study of mouse AT revealed the existence of a lipid 
laden Tim4+ ATM population with a have a high lysosomal activity (chapter 3&4). Up 
to this date, there is no study showing the presence of Tim4+ ATMs in human. 
Interestingly, timd4, the gene coding for Tim4, has been highlighted to be associated 
with dyslipidaemia in genome wide association studies (Kathiresan et al. 2009a; 
Weissglas-Volkov et al. 2013; Teslovich et al. 2010). In mouse, ATMs seem to 
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influence the level of FFA in the blood, thus it is important to determine if Tim4+ 
ATMs are also present in human and could influence lipid homeostasis.  
6.2 Aim 
The aim of this chapter is to gather preliminary evidences that Tim4+ 
macrophages are also present  in human adipose tissue and if they are to verify that 
human Tim4+ ATMs present with the same high lipid content and lysosomal activity 
characteristic of mouse Tim4+ ATMs. 
6.3 Experimental design 
In collaboration with Mr Damian Mole (University of Edinburgh, CIR), I 
obtained omental adipose tissue samples from patients who were undergoing 
laparoscopic surgery for laparoscopic cholecystectomy for biliary colic (surgery for 
gallstones without active inflammation). In collaboration with Dr Roland Stimson 
(University of Edinburgh, CVS), I obtained subcutaneous and omental adipose tissue 
from patients undergoing hernia repair or laparoscopic gastric bypass. This was done 
under Research Ethics Committee approval and after gaining informed consent in 
collaboration with the Clinical Research Facility (CRF). All cell numbers coming from 
this study were given after analysis by Dr Lucy Jackson-Jones (University of 
Edinburgh, CVS / now in Lancaster). All subjects were considered as non-inflamed 
patients.  
  




6.4.1 Tim4 is expressed by the majority of CD14+ cells in the 
omentum and SAT 
To better study ATM population, flow cytometry analysis of omentum and 
subcutaneous AT was done using markers defining monocytes and macrophages. I 
used the markers CD14 and CD16 which define in the blood three distinct populations:  
CD16+CD14- non-classical monocytes (P1), CD16+CD14+ intermediate monocytes 
(P2) and CD16-CD14+ classical monocytes (P3) (K. L. Wong et al. 2011; Patel et al. 
2017). All three populations could be found in human VAT and SAT (Figure 6.1A). 
P2 and P3 expressed Tim4 (Figure 6.1B) and had other macrophage characteristics 
such as the expression of HLA-DR, CD206, CD163, CD64 and CD62L (Figure 6.1C). 
CD16+CD14- cells expressed none of these macrophage markers thus appeared to be 
different from the population found in the blood (K. L. Wong et al. 2011; Patel et al. 
2017). CD16+CD14+ cells had intermediate expression of these markers and CD16-
CD14+ had the highest expression of these markers. Hence, this indicated that Tim4 is 
expressed on CD16-CD14+ ATMs and that potentially its expression is induced on 
“intermediate monocytes” as they differentiate into ATMs in situ. 
  




 Figure 6.1 Tim4 is expressed on CD14+ ATMs alongside with other macrophage 
markers.  
A Density plot representative of CD45+Lin-CD11b+ cells in omentum of obese male 
(BMI 34) showing 3 populations of macrophages in the tissue : CD16+ CD14- (P1), 
CD16+CD14+ (P2) and CD16- CD14+ (P3). B Histograms showing Tim4 expression 
on these subsets and the fluorescence minus one (FMO) as a negative control. C 
Histograms showing the expression of other macrophage markers on these subsets. 




Chapter 6 Tim4+ macrophages are present in human AT 
 
 120 
ATMs could be further separated by subsets according to CD163 and CD206 
expression. Four subsets of ATMs were found: CD163+CD206+, CD163+CD206- , 
CD163-CD206+ , CD163-CD206- . Overall, Tim4 was more highly expressed in the 
CD163+ subsets, independently of CD206 expression and was only lowly expressed in 
CD163-CD206+ (Figure 6.2). Thus CD163 could be used as a marker for Tim4 ATMs.  
Figure 6.2 CD163+ ATMs had a higher Tim4 fluorescence intensity  
Density plot representative of CD45+Lin-CD11b+CD14+ cells in omentum of obese 
male showing Tim4 expression on different subsets and the fluorescence minus one 
(FMO) as a negative control. The histograms y axis represent the percentage of 
maximum intensity 
 
6.4.2 Not all ATM populations show a positive correlation 
between their number and hips to waist ratio 
Visceral adipose tissue expansion during obesity is associated with 
macrophage recruitment in human (Weisberg et al. 2003). Notably CD11c+CD163+ 
ATMs and CD11c+CD206+ ATMs were found positively associated with the BMI 
(Nakajima et al. 2016; J. M. Wentworth et al. 2010). ATM number can be related to 
BMI, but the WHR is a better indicator of risks to develop metabolic disease (Smith 
2015). Hence, the ATM subsets were reported to the WHR.  
Study of ATM cell number according to subsets revealed heterogeneity in 
number increase with waist to hips ratio (Figure 6.3). Tim4 was not on the panel during 
this study but as mentioned in 6.4.1, CD163+ ATMs are Tim4+. As reported, we found 
that the total number of CD163+ ATMs was highest in obese individuals (waist to hips 
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ratio >0.9 (Obese individuals) (cell number given by Lucy Jackson-Jones). However, 
a sub-population of CD163+CD206- ATMs tended to stay stable. All CD206+ ATMs 
were increased with obesity, independently of their expression of CD163 (Figure 6.3).  
 
 
Figure 6.3 Not all ATM populations show a positive correlation between their 
number and hips to waist ratio.  
Human omentum were digested and cells were analysed by flow cytometry (n= 7). 
The number of cells was correlated to the waist to hips ratio for each subject. 
Correlations were assessed with the Pearson correlation coefficient with p value>0.05 
considered as significant.  
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6.4.3 Human omentum contained Tim4+ cells disposed in 
crown like structures  
To assess the spatial localisation of Tim4+ ATMs, wholemount staining with 
lysotracker, LipidTox and Tim4 showed that the omentum (male, BMI = 32 (obese)) 
contained Tim4+ cells disposed around adipocytes in a crown like shape in the 
omentum (Figure 6.4). Other cells (Tim4-) were also present in the CLS. In addition, 
Tim4+ cells contained distinct lysosomes and neutral lipid vesicles which appeared to 
colocalise with Tim4 staining (Figure 6.4B).  
 
Figure 6.4 Human omentum had Tim4+  ATMs that contained lysosomes and 
were lipid laden.  
A Wholemount immunofluorescence staining and confocal imaging showing 
lysosomes stained with Lysotracker (red), neutral lipids stained with Lipidtox (green) 
and Tim4 (grey) (Leica SP5 x40). B Zoom in of selected area (yellow) in the figure A. 
Scale bar represents 50µm. 
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  The SAT also contained lipid laden Tim4+ cells with very active lysosomes 
(Figure 6.5 and Figure 6.6). Some Tim4+ ATMs appeared to contains lysosomes 
(Figure 6.6B, number 1 and 2),  but some did not (Figure 6.6B, number 3), suggesting 
that lysosomes might by inducible or that subsets of macrophages exist within the 
Tim4 population, some being more active than others.  
 
Figure 6.5 Human SAT had lipid laden Tim4+ ATMs that contained lysosomes  
Wholemount immunofluorescence staining and confocal imaging showing lysosomes 
stained with Lysotracker (red), neutral lipids stained with Lipidtox (green) and Tim4 
(grey) (Leica SP5 x40). Scale bar represents 25µm. Images from SAT taken from 2 
obese (BMI>32) subjects.   
 




Figure 6.6 Obese human SAT contained Tim4+  ATMs, which some were filled 
with lysosomes 
A Wholemount immunofluorescence staining and confocal imaging showing 
lysosomes stained with Lysotracker (red) and Tim4 (grey) (Spin disk x40). B Zoom in 
of selected macrophage in the figure A.  
 
 In all pictures analysed from omentum and SAT, the staining for Tim4  did not 
seem to be restricted to the cell surface and had a punctuated appearance partially 
overlaying with the lysosomal staining (Figure 6.4-6.6) 
To test the ability of ATMs to uptake lipids, after purification of macrophages 
by adhesion method of omental SVF, ATMs were fed with LDL-Bodipy (50µg/ml) 
for 4h. Only few macrophages could be found on the plate, which could be improved 
in the future. Tim4+ ATMs were charged in LDL and lysosomes (Figure 6.7, ATM 
number 2-4). However some Tim4- ATMs presented lysosomes but no LDL (number 
1). Hence, lysosomal activity might not be restricted to Tim4+ ATMs, but it seems 
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these macrophages had an affinity for LDL uptake. Moreover, lipids lysosomes and 
Tim4 colocalised in some ATMs (number 2).  
 
Figure 6.7 Tim4+ ATMs (omentum) were able to pick up LDL in vitro 
Adhesion purified ATMs from omentum sample from an obese patient were incubated 
with LDL-Bodipy (green) for 4 hours previous to immunofluorescence staining and 
confocal analysis showing nuclei stained with Dapi (blue), lysosomes stained with 
Lysotracker (red), Tim4 (grey), LDL-Bodipy (green) (Leica SP5).  
  




I confirmed using microscopy and flow cytometry that human omentum and SAT 
contained Tim4+ ATMs (Figure 6.1). Tim4 was expressed heterogeneously across 
macrophages however CD163+ ATMs expressed it the most, independently of  CD206 
expression (Figure 6.2). Moreover, Tim4+ ATMs were lipid laden, contained 
lysosomes and take up LDL, similarly to what was described in mice in previous 
chapters (4 and 5) (Figure 6.6 - Figure 6.7).  
Contrary to murine Tim4+ ATMs that were resident, humans Tim4+ ATMs seem 
to come from the CD16+CD14+ (P2) population, which are intermediate monocytes, 
and thus might have a monocytic origin (Figure 6.1). Some macrophages in human are 
known to be self-replenishing. Indeed, following macrophages at different time points 
after human organ transplant showed that Langerhans cells, alveolar macrophages and 
Kupffer cells from donors could be still present in the recipients years after transplant 
(Schlitzer and Schultze 2017; Davies et al. 2013). Knowing macrophage origin in 
human’s tissues is challenging as there is no specific methods or markers allocated to 
this purpose. Even if ATMs in human contained resident self-replenishing cells, the 
inflammatory status of the patients might skewed the results. The samples collected 
from the analysis of Tim4 ATMs were coming from obese patients (BMI > 30). As 
shown in mouse in chapter 4, obesity increases the amount of cells coming from the 
BM so much that resident cells decrease in proportion in the tissue.  
Multiple studies showed that ATM content correlates with the amount of fat in 
human and their BMI (Curat et al. 2006; Weisberg et al. 2003; Nakajima et al. 2016). 
Here, I showed that even though the cell number of most subsets increased in parallel 
with the WHR, the CD163+CD206-  ATM subset did not (Figure 6.3). The WHR, 
compared to the BMI, acknowledges the fact that not only fat accumulation is a risk 
factor to develop diseases but AT distribution is important too (Smith 2015). Indeed, 
waist accumulation leads to higher risks of cardiovascular diseases and diabetes (Smith 
2015).  
Macrophages accumulate specifically in CLS with obesity in mouse and human 
(Murano et al. 2008). Tim4+ ATMs could be found in what could qualify as CLS in 
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the omentum (Figure 6.4), however they seemed quite sparse in the SAT (Figure 6.6). 
It is reported that other subsets expressing CD11c (CD11c+CD206+) are spatially 
restricted to CLS, while CD11c-CD206+ are found with no defined spatial arrangement 
(John M Wentworth et al. 2010). CD11c+ ATMs can also express CD163 (Nakajima 
et al. 2016). While both CD206 and CD163 are considered as M2-like macrophage 
markers, they have both been shown to be expressed on inflammatory CD11c+ ATMs 
(Martinez and Gordon 2014) which secretes large amount of TNF, MCP1 and IL 6, 
cytokines inducing AT inflammation during obesity (Zeyda et al. 2007). Therefore, at 
this stage of the study, I can’t exclude that Tim4 could also be expressed by CD11c+ 
ATMs, as it was present on both CD206+  and CD163+  ATMs (Figure 6.2). 
The intense Lipidtox staining found in Tim4+ ATMs is reminiscent of the 
foamy CD14+CD64+ ATMs described in the omentum of obese human (Shapiro et al. 
2013) and of the lipid laden CD11c+ ATMs described in human omentum (J. M. 
Wentworth et al. 2010). This raises the question of the exact nature of the lipid staining 
found in Tim4+ ATMs: Is it an accumulation of lipid droplets characteristics of foamy 
ATMs or is it lipid vesicles transiting to the lysosomes for their catabolism as described 
by Xu et al? The frequent association of Tim4, lipid neutral staining and lysosomal 
staining in Tim4 ATMs would indicate that Tim4 is associated with the second type 
of lipid laden ATMs. Interestingly, CD11c+CD206+ contains more transcript related to 
lipid handling and lipid oxidation, as well as mRNA coding for lysosomes (J. M. 
Wentworth et al. 2010). More work needs to be done to determine whether Tim4 is 
associated with a lysosomal lipolysis signature in human.  
The correct degradation of lipids by lysosomes is critical. Lysosomal acid 
lipase deficiency (LAL-D, also known as Wolman disease) is a genetic disorder in 
human, arising from a mutation in the LIPA gene. It results in accumulation of lipids, 
notably cholesterol esters and TG, in the liver, arteries, spleen… (Reiner et al. 2014) 
Indeed, cells can’t break down LDL into free cholesterol and FFA and lipids 
accumulate within lysosomes. LAL-D patients present dyslipidaemia ( elevated TG 
and LDL) and enlarged lipid laden hepatocytes, as hepatocytes can’t lyse LDL via 
their lysosomes, but also lipid laden Kupffer cells. BM transplant had successfully 
treated few patients with LAL-D but the procedure is risky (Krivit et al. 2000). 
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However, it suggest the importance of HSC derived cells, and potentially BM derived 
macrophages in human lipid metabolism via LAL, which was also the case in mouse 
(Ouimet et al. 2011; Chistiakov, Bobryshev, and Orekhov 2016; S. C.-C. Huang et al. 
2014).  
Conclusion 
In this chapter, I presented preliminary data confirming the existence of Tim4+ 
ATMs in human omentum and SAT. More experiments need to be done to carefully 
assess the expression of Tim4 on the various ATM subsets previously described in the 
literature and that I identified. In vitro experimentation could be conducted from 
patient AT explants combined with Tim4 blockade and the measurement of net 
lipolysis to have an idea of the role of these ATMs in lipid metabolism. The limitation 
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In this thesis, I investigated the heterogeneity of ATMs in a murine model and 
identified several subsets of ATMs expressing distinct surface markers. Notably, these 
subsets showed a great heterogeneity in the mechanisms controlling their turnover in 
the AT.  After partial body irradiation and i.v. reconstitution with donor mice, I showed 
that Tim4+ ATMs had a very low input from the donor BM after 8 weeks, contrary to 
CD11c+ ATM. Therefore, the expression of Tim4 characterised resident ATMs in the 
mesenteric, subcutaneous and gonadal AT. This newly described subset did not rely 
on monocyte derived macrophages to increase its pool during HFD induced obesity, 
but increase in number by proliferation. Even though their number increased during 
AT expansion, monocyte derived macrophages colonised the tissue and accounted for 
most of the increase in macrophage number during HFD.  
Interestingly, Tim4+ ATMs were lipid laden in lean and obese GAT, raising the 
question of their role in the control of lipid influx. Indeed, macrophages are known to 
participate in AT lipolysis and FFA release, via an intracellular process of lysosomal 
activation and catabolism of lipids taken up by ATM (X. Xu et al. 2013). Tim4+ ATMs 
had a high lysosomal activity which correlated with their ability to uptake lipids. In 
vivo blockade of Tim4 with monoclonal antibodies affected the levels of FFA in the 
plasma of mice. Indeed, compared to control mice fed the same HFD for 1 day or 8 
weeks, the mice injected with aTim4 blocking antibodies had lower plasmatic FFA 
levels. Examination of the content and lysosomal activity of Tim4+ macrophages 
coming from different tissues revealed that blocking Tim4 blocked lipid uptake and 
reduced lysosomal activity, thus could explain a decrease in lipid catabolism and the 
decrease on FFA in the plasma. Interestingly, there was some difference in lipid uptake 
dependent on the tissues from which macrophages were taken, with ATMs and liver 
macrophages being more efficient at taking up lipids than peritoneal macrophages. The 
exact mechanism of the involvement of Tim4 and lipid uptake has still to be 
determined, but it seemed that Tim4 colocalised with lysosomes and might be involved 
in the internalisation of lipids and formation of phago-lysosomes, maybe in 
conjunction with other receptors. Tim4+ ATMs were also present in humans (omentum 
and SAT), in rather large proportions, and did also contain lipids and lysosomes. Their 
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role in lipid metabolism in human will be of interest as already several GWAS pointed 
at timd4 and its association with dyslipidaemia.  
The proposed mechanism of action of Tim4 macrophages is summarised in the figure 
below (Figure 7.1).  
 
Figure 7.1 Proposed mechanism of action of Tim4+ macrophages 
After a meal, lipids enter the bloodstream, mainly in the form of TG rich 
lipoproteins which are taken up by cells to sustain their need for energy and anabolism, 
while excess TG are stored by adipocytes. A Tim4+ macrophages in AT and liver are 
able to pick up excess TG from the environment to buffer TG in the tissue and to 
release FFA which will become available for other organs. Tim4 is involved in the 
uptake of lipid particles and their progress to the lysosomes where they are hydrolysed 
into FFA and released from the tissue to the bloodstream. Blocking Tim4 (B) decreases 
lipid uptake by macrophages and their lysosomal degradation which reduces FFA 
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7.2 Heterogenous macrophages in AT 
Using partial BM chimeras , I showed the heterogeneity of recruitment of ATMs 
in the tissue. While a number of studies have now shown that ATM can fulfil a number 
of different and sometimes antagonist functions, there is a critical lack of 
characterisation of ATM subsets. I hope that my study will contribute to the 
establishment of a universal gating strategy by flow cytometry for ATMs that would 
help make future work on ATMs more easily transferable from one lab to another. 
Amano and colleagues showed that 8 weeks of HFD induce (in male C57Bl/6J) 
macrophages proliferation (Amano et al. 2014). In their gating strategy they use 
CD45+Siglec-F−CD11b+F4/80+  to define ATMs. They don’t segregate F4/80high or 
F4/80low ATMs, and in my opinion, missed some ATMs in their gating (notably some 
F4/80low, which, if included, could lower their number of proliferative cells). They do 
acknowledge that there is a basal ATM proliferation in lean mice (Amano et al. 2014). 
Adding Tim4 in their study could have revealed that these were the ones proliferating, 
as well as some F4/80high ATMs. A recent study demonstrated that ATM recruitment 
was CCR2 independent at the early stage of HFD (2 weeks) and that these CD11c- 
ATMs were proliferating, as measured by PKH26, a dye injected i.p. that is 
phagocytosed by macrophages and is diluted with time (Muir et al. 2018). In this 
thesis, I propose that Tim4+ ATMs are a critical subset for the homeostasis of AT, 
mopping fat spill-over coming from dead adipocytes and high fat rich meals, but that 
they rapidly become saturated during long term high fat feeding. Excess fat that can’t 
be processed by Tim4+ ATMs are taken up by CD11c+ ATMs that accumulate 
progressively more lipids (Carey N Lumeng, Bodzin, and Saltiel 2007; Morris et al. 
2013). However Tim4 uptake of lipids could dampen inflammation, as my data show 
that MHCIIlowTim4+ ATMs uptake lipids. When put in culture, PEC macrophages 
from Tim4 KO mice produce more TNFα than WT (K. Wong et al. 2010). The reduced 
capacity of Tim4+ ATMs to buffer lipids in HFD, may be due to their slower turnover 
compared to BM derived macrophages. The era of single cell sequencing is allowing 
the definition of more subsets and moving towards defining subset link with specific 
functions will be critical in the future. 
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7.3 Tim4 is not unique to ATMs 
A number of studies showed that ATMs are involved in lipid trafficking (X. Xu 
et al. 2013; Reilly and Saltiel 2014; Kosteli et al. 2010a; Prieur et al. 2011). This thesis 
implies that Tim4 expressing macrophages alone might play a big role in lipid 
trafficking, as in vivo blockade was sufficient to decrease FFA in the plasma of mice 
after HFD. Tim4 is expressed by a macrophages in various organs but also on other 
cell types. Dendritic cells (DCs) also express Tim 4 and can become lipid laden in 
tumour bearing mice (DCs from spleen) and results in default of antigen presentation 
(Gardner et al. 2014; Pearce and Everts 2015). However no studies have been done on 
a possible role of DCs in lipid metabolism. Tim4 expressing macrophages are present 
in several murine organs: for example, spleen, liver, peritoneal cavity, gut and skin (K. 
Wong et al. 2010; Shaw et al. 2018; Yanagihashi et al. 2017). Other than AT, gut and 
liver are the organs which have a role in lipid metabolism: the gut for digestion of 
dietary lipids and formation of chylomicrons and the liver for formation of other 
lipoproteins and in cholesterol metabolism (Feingold and Grunfeld 2000). Blocking of 
Tim4 using anti-Tim4 antibodies did not specifically targeted ATMs so I can’t attribute 
the decrease in FFA only to ATMs. Blocking Tim4 in vivo targeted the receptor on 
GAT and PEC macrophages, but also on Kupffer cells (data not shown). Kupffer cells 
have a transcriptional profile enriched with genes involved in lipid metabolism, and 
the liver is central in the control of LDL levels in the bloodstream (Remmerie and 
Scott 2018). Chronic release of FFA by AT can lead to ectopic accumulation of fat in 
the liver (non-alcoholic fatty liver disease). In the setting of HFD, it would be 
interesting to test whether blocking Tim4 also affect the amount of fat deposition in 
the liver. 
7.4 Mechanism of lipid uptake by Tim4 
Tim4 blockade in vitro decreases LDL and CM uptake by ATMs. The fact that 
less lipids are taken up could explain the decrease in lysotracker activity observed. But 
in vivo, it is not clear what lipids Tim4 ATMs would uptake.  
Apoptotic cells  
In vivo Tim4 blockade has been performed in ldlr-/- mice fed a HFD for 4 
weeks. Tim4 blockade increased apoptotic cell numbers in atherosclerotic areas and 
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as they accumulated, the tissue became necrotic (Foks et al. 2016). Hence Tim4+ 
macrophages in this setting, seem to be mainly involved in clearance of apoptotic cells 
containing large amounts of lipids (foam cells) (Foks et al. 2016). No impact on 
cholesterol or TG levels was observed in the plasma of these mice, however the levels 
of FFA were not assessed. In addition, the experiments were performed in ldlr-/- mice 
which are highly dyslipidemic which could have masked the effect of blocking Tim4 
on lipidemia. It would be interesting to look at atherosclerotic lesions in C57Bl/6 mice 
after Tim4 blockade. To develop atherosclerosis these mice need 14 weeks of high 
cholesterol diet (Schreyer, Wilson, and LeBoeuf 1998).  
In the atherosclerotic plaque Tim4+ macrophages internalised apoptotic 
macrophages that had engulfed oxLDL. This could suggest that Tim4+ macrophages 
acquire their lipids by ingesting lipid laden cells and not LDL directly in this case. In 
AT, apoptotic adipocytes are surrounded by macrophages (CLS) (Murano et al. 2008). 
It was demonstrated in vitro that macrophages can exocytose their lysosomes to 
facilitate adipocyte degradation (exophagy) (Haka et al. 2016). Macrophages can then 
degrade large amount of lipids, and rapidly become foamy (24 hours) (Haka et al. 
2016). It is possible that all macrophages are able to uptake apoptotic cells, but it is 
unclear what becomes of the lipids (degraded via lysosomes or stored as lipid droplet 
/ CE). Either Tim4+ macrophages also become foamy and accumulate lipids or they 
are present in these areas to clear the foamy cells.  
Direct uptake of lipids  
PS is a glycerophospholipid recognised by a metal ion-dependent pocket on 
the N-terminal immunoglobulin-fold extracellular domain of Tim4 (Santiago et al. 
2007). Very little has been done on Tim4 signalling. In contrast, other PS receptors, 
its intracellular domain does not have any tyrosine kinase activity. Lipoproteins 
naturally contain phospholipids, including PS. Tim4 can interreact with glycerol and 
fatty acid after PS recognition on dead cells (Santiago et al. 2007). It would be 
interesting to block PS on lipids and look at their uptake by Tim4 ATMs to identify 
what is recognised by these macrophages.  
Chapter 7 Discussion 
 
 135 
Macrophages produce lipase (LpL) to facilitate the uptake of TG rich 
lipoproteins (Aouadi et al. 2014; M. Takahashi et al. 2013; Babaev et al. 1999). 
Silencing LpL expression in ob/ob mice ATMs, using siRNA, decreased the amount 
of lipid laden macrophages and increased FFA levels in the blood as well as glucose 
intolerance (Aouadi et al. 2014). In addition, LpL silencing reduced CD36 expression 
on macrophages. Therefore LpL could facilitate lipid uptake by AT and ATMs 
themselves, and control FFA levels in the blood. Interestingly in this experiment, the 
fact that LpL was silenced in all macrophages increased FFA levels in the blood 
whereas blocking Tim4 decreased the amount of FFA. It is possible that lipids that are 
not taken up by Tim4 are phagocytosed by other macrophages which are unable to 
process lipids, either due to a lack of lysosomal biogenesis proportional to the amount 
of lipid taken, or because there metabolism is shifted from OXPHOS, and they don’t 
use FA as a source of energy. Using SeaHorse technology could inform about the 
mitochondrial activity (OCR) of Tim4 ATMs, in comparison to other subsets.  
CD36 expression was higher on Tim4+ ATMs challenged with LDL compared 
to other ATMs, suggesting that these macrophages could be more efficient at lipid 
uptake. After IL-4 stimulation of BMDM, macrophages (M2) express more CD36 and 
take up more LDL and VLDL than unstimulated BMDM (M0) (X. Xu et al. 2013). 
However, BMDM from CD36-/- treated with IL-4 picked up less LDL and VLDL than 
M2 and M0 macrophages, suggesting the role of CD36 for lipoproteins uptake (X. Xu 
et al. 2013). These in vitro experiments, after differentiation of BMDM, do not 
integrate the environment “imprinting” that I observed during experiments involving 
macrophages from the GAT, PEC and liver. It would be interesting to do the same 
kind of experiments on CD36-/-  but using primary macrophage coming from the GAT, 
PEC and liver, and looking at the differential lipid uptake by the different subsets. 
Directed uptake of oxidised lipids  
LDL oxidation (oxLDL) or acetylation increase their uptake by macrophages 
(Miller et al. 2010). These modifications also allow LDL to be scavenged by other 
receptor than the classical LDL-receptor, which is a receptor ubiquitously expressed 
(Miller et al. 2010). For example, CD36 is involved in oxLDL uptake (Sheedy et al. 
2013; Jay et al. 2015). The presence of a lipoxygenase (12/15LO) on Tim4+ 
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macrophages directs apoptotic body uptake to those macrophages (Uderhardt et al. 
2012). Indeed, 12/15LO oxidise esterified fatty acids (phosphatidyl ethanolamine PE) 
which interferes with the ability of other macrophages to bind apoptotic cells by 
binding MFG-E8. Indeed, MFG-E8 creates a bridge between apoptotic cells and other 
macrophages, not expressing Tim4 thus enabling them to engulf them. In arachidonate 
15 LO (ALOX15) KO mice,  the absence of ALOX15 during induced peritonitis, 
allows the uptake of apoptotic cells by Ly6chigh monocytes, via MFG-E8, and 
enhanced inflammation (Uderhardt et al. 2012). Hypothetically, 12/15 LO could also 
oxidise lipids such as LDL and enhance a targeted engulfment by Tim4 macrophages, 
with the help of CD36. 12/15 LO can induce CD36 expression in macrophages after 
IL-4 stimulation. (J. T. Huang et al. 1999). The need of ALOX15 in ATMs to clear 
dead cells was also demonstrated recently. Co-culture of F4/80+ ATMs with apoptotic 
adipocytes increased ALOX15 expression and if ALOX15 was pharmacologically 
inhibited, there was a delay in lipid clearance from adipocytes, by ATMs (Kwon et al. 
2016). It is not known if all macrophages express ALOX15, but since the expression 
of ALOX15 is associated with the expression of Tim4 in peritoneal macrophages, it is 
possible that the expression of ALOX15 is also restricted to Tim4+ ATMs in AT. 
7.5 Tim4: good or evil ? 
Tim4 blockade limited the amount of FFA release in the bloodstream after 
HFD (in the non-fasted state). This could potentially improve the metabolic status of 
patients with dyslipidaemia, as lowering FFA can improve insulin resistance (Boden 
2008). SNPs in TIMD4 in GWAS have been linked with dyslipidaemia. The SNP 
rs1553318, present in 65% of the studied population, was associated with an increase 
in TG, LDL and cholesterol in the plasma (Surakka et al. 2015), while other SNPs 
(rs6882076, rs4704727, rs1501908, rs2036402) were associated with a decrease of the 
same parameters (Kathiresan et al. 2009b; Spracklen et al. 2017; Teslovich et al. 2010; 
Willer et al. 2013). None of the SNP found in Timd4 are found in a coding region and 
therefore are more likely to affect the gene expression level of Tim4 than its structure 
(except if the SNP alters the splicing of Timd4 mRNA). Since I found that Tim4 was 
expressed by the majority of ATM in the 3 obese subjects I studied, it would be critical 
to study if there are any variability in the frequency of Tim4+ ATM or the level of 
Chapter 7 Discussion 
 
 137 
expression of Tim4 in subjects of varying BMI and metabolic dysfunction and 
correlate this with the genotype of this subjects. Tim4 and TIMD4 could be involved 
in a “lean phenotype” to limit AT expansion by directing lipid efflux to the 
bloodstream for muscle use after a meal. However, evolution of society and western 
lipid rich diet means that Tim4 activity may now be more linked to cardiovascular 
diseases via excess FFA release in the circulation due to our lipid rich diet and their 
deposition in liver, muscle and arteries.  
To conclude, exploring and exploiting the heterogeneity of macrophages in 
adipose tissue and other compartments could lead to the development of efficient 
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